WO1997020510A1 - Radio frequency energy delivery system for multipolar electrode catheters - Google Patents

Radio frequency energy delivery system for multipolar electrode catheters Download PDF

Info

Publication number
WO1997020510A1
WO1997020510A1 PCT/US1996/019746 US9619746W WO9720510A1 WO 1997020510 A1 WO1997020510 A1 WO 1997020510A1 US 9619746 W US9619746 W US 9619746W WO 9720510 A1 WO9720510 A1 WO 9720510A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrode
electrodes
temperature
control network
signal
Prior art date
Application number
PCT/US1996/019746
Other languages
French (fr)
Inventor
Sean Mackey
Original Assignee
C.R. Bard, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.R. Bard, Inc. filed Critical C.R. Bard, Inc.
Priority to EP96943705A priority Critical patent/EP0866675B1/en
Priority to DE69630393T priority patent/DE69630393T2/en
Priority to JP52149797A priority patent/JP3746521B2/en
Publication of WO1997020510A1 publication Critical patent/WO1997020510A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/0016Energy applicators arranged in a two- or three dimensional array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00357Endocardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00375Ostium, e.g. ostium of pulmonary vein or artery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00595Cauterization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/0066Sensing and controlling the application of energy without feedback, i.e. open loop control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • A61B2018/00678Sensing and controlling the application of energy using a threshold value upper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • A61B2018/00708Power or energy switching the power on or off
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/0075Phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00767Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00797Temperature measured by multiple temperature sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00815Temperature measured by a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00821Temperature measured by a thermocouple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00827Current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00892Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1246Generators therefor characterised by the output polarity
    • A61B2018/1253Generators therefor characterised by the output polarity monopolar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1273Generators therefor including multiple generators in one device

Definitions

  • This invention relates to electrode catheters and, m particular, to a power supply arrangement for simultaneously delivering single-phase energy to multiple electrodes of an electrode catheter.
  • Cardiac dysrhyth ias are commonly known as irregular heart beats or racing heart.
  • Two such heart rhythm irregularities are the Wolff-Parkinson-White syndrome and AV nodal reentrant tachycardia. These conditions are caused by an extraneous strand of muscle fiber m the heart that provides an abnormal short-circuit pathway for electric impulses normally existing m the heart.
  • the accessory pathway causes the electric impulses that normally travel from the upper to the lower chamber of the heart to be fed back to the upper chamber.
  • VT ventricular tachycardia
  • Atnal fibrillation is the most commonly occurring type of arrhythmia. It is associated w th increased morbidity and mortality due to a higher incidence of thromboembolic events and hemodynamic compromise.
  • the ventricular response can be controlled by catheter ablation or modification of the atriovent ⁇ cular (AV) nodal region, but this procedure is palliative since AF and ts related risks are persistent.
  • Pacemakers may be used to prevent recurrence of paroxysmal AF by either preventing the sinus bradycardia that triggers AF or reducing the mteratrial conduction delay.
  • Non-surgical procedures such as management with drugs are favored in the treatment of cardiac dysrhythmias .
  • arrhythmias are not treatable with drugs, for example, disabling drug resistant AF, and have previously required surgery.
  • various incisions are made in the heart to block conduction pathways and thus divide the atrial area available for multiple wavelet reentry and abolish the arrhythmia.
  • an Automatic Implantable Cardioverter/Defibrillator can be surgically implanted into the patient, as described m U.S. Patent No. 4,817,608 to Shapland et al . While these surgical procedures can be curative, they are associated with increased morbidity and mortality rates, and are extremely expensive. Even the use of an AICD requires major surgical intervention. However, patients of advanced age or illness, for example, cannot tolerate invasive surgery to excise the tachycardia focus which causes dysrhythmias.
  • Non-surgical, minimally invasive techniques have been developed which are used to locate cardiac regions responsible for tachycardia, and also to disable the short-circuit function of these areas. According to these techniques, electrical energy shocks are applied to the endomyocardium to ablate cardiac tissue in the arrhythmogenic regions and produce scars which interrupt the reentrant conduction pathway ⁇ .
  • the regions to be ablated are usually first determined by endocardiac mapping techniques . Mapping typically involves percutaneously introducing an electrode catheter into the patient, passing the electrode catheter through a blood vessel (e.g.
  • a tachycardial focus is located, as indicated in the electrocardiogram recording, it is marked by means of a fluoroscopic image so that cardiac arrhythmias at the located site can be ablated.
  • a conventional electrode catheter provides electrical energy shocks to the tissue adjacent the electrode to create a lesion in the tissue.
  • One or more suitably positioned lesions will create a region of necrotic tissue which will disable the malfunction caused by the tachycardial focus.
  • Ablation is effected by applying energy to the catheter electrodes once the electrodes are in contact with the cardiac tissue.
  • the energy can be, for example, RF, DC, ultrasound, microwave, or laser radiation.
  • RF ablation is preferable because it does not require that the patient be anesthetized, and it produces more circumscribed and discrete lesions. Further, it avoids injury that may be caused by high voltages, for example, DC shock.
  • RF energy is delivered between the distal tip of a standard electrode catheter and a backplate, there is a localized RF heating effect. This creates a well-defined, discrete lesion slightly larger than the tip electrode. The small size of the lesions produced by RF ablation has been perceived as one of the limitations of this technique.
  • the lesion created by the simple RF technique delivered through a standard electrode catheter may not be large enough to ablate enough tissue to block ventricular tachycardia, for example, because the electrode tip area is usually only about 0.3 mrr and the exit site of VT i ⁇ typically only locatable to within 4-8 cm 2 of the earliest site recorded by the endocardiac mapping catheter.
  • flexibility of the tips of such catheters is reduced, and a stiffer catheter tip increases the risk of myocardial wall perforation, which in turn increases the morbidity rate of ablation procedures using such catheters.
  • a ra ⁇ io- frequency ablation sy ⁇ tem for biological tissues in which the power, voltage, or temperature delivered to multiple electrodes may be dynamically controlled, and m which the electrodes may be simultaneously energized in phase with each other to achieve a de ⁇ ired lesion pattern
  • the ⁇ y ⁇ tem comprise ⁇ an electrode catheter having a generally longitudinally extending shaft which defines a lumen, and an array of externally conductive, individually connected electrode ⁇ arranged in spaced serial relation along the shaft
  • the electrode catheter further comprises a plurality of temperature sensors each of which is thermally associated with a different electrode m the array to provide a temperature signal representative of the temperature of that electrode
  • a plurality of RF amplifiers are electrically connected to different electrodes in the array.
  • Each RF amplifier provides drive signals representative of the voltage and current applied to the electrode to which it is connected
  • a feedback control network is provided with these drive signal ⁇ along with the temperature signal for the same electrode, m response to the received temperature and drive ⁇ ignal ⁇ of a particular electrode, the feedback control network provides an amplification signal to each RF amplifier
  • a RF sine wave oscillator which has an output that is separately amplified in phase by each of the RF amplifiers m accordance with the amplification signal from the feedback control network for that RF amplifier, is also provided to independently drive each of the electrodes in the array of electrodes m phase with each other.
  • a modular power supply arrangement for a rnultipolar ablation device comprises a mother board including one or more receptacles adapted to receive a module, a sine wave oscillator which has an output electrically connected to the receptacle, and a feedback control network which (1) receives input signals from the module m the receptacle, (2) processes the input signals, and (3) provides an amplification signal which is responsive to the input signals to that nodule
  • the modular power supply arrangement further comprises at least one module removably connected to the receptacle.
  • the module include ⁇ a RF amplifier for driving a particular pole of the multipolar ablation device in pha ⁇ e with the oscillator output in accordance with the amplification signal from the feedback control network, and a signal sensor for sensing predetermined operating parameters of the particular pole of the multipolar ablation device and providing the input signal ⁇ to the feedback control network.
  • Two or more ⁇ uch modules are used to energize multiple electrodes. Multiple electrodes are controlled by the modular power supply arrangement when multiple receptacles are provided, or when modules which are configured to energize multiple electrodes are provided, or both.
  • the module may be configured with multiple RF amplifiers, each driving a different pole of a multipolar ablation device m phase with the sine wave oscillator output and m accordance with the amplification signal from the feedback control network. Further, each module according to this modification is configured with a plurality of signal sensors for sensing predetermined operating parameters of the multipolar ablation device and providing the input ⁇ ignal ⁇ to the feedback control network.
  • FIG. 1 schematically illustrates a RF power supply arrangement for an ablation catheter according to the invention
  • Fig. 2 is a diagrammatic view of the distal end of an ablation catheter which is carrying multiple electrodes and temperature sensors;
  • Fig. 3 s a detailed schematic illustration of a module for insertion into the power supply arrangement of Fig
  • Fig. 4 i ⁇ a detailed schematic illustration of a modified module for insertion into the power supply arrangement of Fig. 1, the modified module being adapted for use with four electrodes; and
  • Fig. 5 is a detailed schematic illustration of the control network of Fig. 1.
  • Fig. 1 a schematic illustration of a power supply arrangement 100 according to the present invention which is adapted to maintain constant power, voltage, or temperature at each electrode of a multielectrode catheter.
  • Arrangement 100 is preferably constructed on a mother board 102 and includes a sine wave oscillator 104, a control network 106, and a plurality of receptacle ⁇ 108 adapted to receive plug-in daughter boards or modules 110.
  • Each daughter board 110 is computer addressable over a bidirectional data and addre ⁇ s bu ⁇ 114, and contain ⁇ feedback loop control circuitry for individually maintaining one or more electrode ⁇ at a constant power, voltage, or temperature.
  • a computer 112 operatively attached to and in signal communication with the bus 114 preferably includes operating software which is adapted to provide control signals to the modules 110 for individually controlling the electrodes of a multielectrode catheter.
  • the computer 112 also preferably includes appropriate input/output features and ⁇ oftware for dynamically di ⁇ playing the current, time, voltage, power, temperature, or impedance of the individual electrodes, or displaying other signal ⁇ such as electrocardiograms (EKGs) .
  • the sine wave o ⁇ cillator 104 on the mother board provides a predetermined frequency drive signal in the range of 20 to 500 Khz to each of the odule ⁇ 110 ⁇ o that each of the RF amplifier ⁇ , which are part of the module ⁇ 110, m the power supply arrangement 100 i ⁇ driven in phase with the others.
  • the lower end of the drive signal range (that is, about 20 - 50 Khz) is conventionally used at a relatively low-amplitude level to determine catheter contact with the endocardium without stimulating the heart as contact measurements are being made At higher frequencie ⁇ , the heart is not stimulated at the amplitudes used in the ablation procedure.
  • the power supply arrangement 100 of Fig. 1 has utility, for example, with medical devices such as catheter 200, the distal end of which is illustrated m Fig. 2
  • the catheter 200 is an ablation catheter configured with multiple electrodes, serially spaced in an axial direction along the catheter.
  • the catheter 200 is conventionally constructed of an insulative, biocompatable tubing material, and has an outside diameter small enough to pas ⁇ through a vascular system from an introducer site to a desired cardiac chamber, and has the capability to negotiate the vascular system In other words, it is sufficiently flexible to be advanced through a tortuous vasculature, yet possesses sufficient column strength to permit its advancement therethrough
  • the catheter 200 has a tip electrode 202 which occupies the distal 2-4 mm of the catheter.
  • the tip electrode 202 is made of platinum and is attached directly to the distal end of the catheter 200.
  • a refractive material (not shown) may be interposed between the tip electrode 202 (or the other electrodes) and the catheter 200 to prevent melting of the supporting catheter during and just after ablation energy ha ⁇ been applied to the electrode
  • the catheter 200 ha ⁇ externally conductive ring electrode ⁇ 204 ⁇ paced therealong in serial manner Three ring electrodes 204 are illustrated in Fig. 2, however, the catheter 200 can have an arbitrarily large number of electrodes. For example, Dr.
  • Michel Haissaguerre ha ⁇ proposed a catheter construction for AF treatment which has thirteen ring electrodes 204 and a single tip electrode 202
  • the ring electrode ⁇ 204 are spaced from each other (and the tip electrode 202) by insulative regions 206, and each can be of an arbitrary axial length. Presently, they are preferably approximately 2 mm in axial length. While the ring electrodes 204 can be spaced 1 - 3 mm apart, as described m more detail below m connection with an ablation system according to the invention, it is presently preferred that they be spaced 1 mm apart .
  • Each electrode 202, 204 has a separate conductive lead 210 attached thereto which extends proximally through at least one lumen 212 in the catheter 200 to a connector 214 (not shown) .
  • a temperature sensor 208 disposed adjacent the electrode for providing an electrical signal indicative of the temperature of the electrode.
  • the temperature sensor 208 can be a thermocouple, thermistor, or resistive thermal device ("RTD") .
  • RTD resistive thermal device
  • Each temperature sensor 208 has a conductive lead 216 attached to it which extends proximally to the connector 214.
  • a cable 218 houses the electrode and temperature sensor leads 210, 216 between the proximal end of the catheter 200 and the connector 214. The connector mates with a terminal on the module 110.
  • the module 110 communicates with the computer 112 via the two-way bus 114 via an electrical connection between the module 110 and the receptacle 108 of the mother board 102.
  • a digital-to-analog converter (DAC) 302 is arranged in conventional manner to be addressed by the computer 112, as will be readily understood by those of ordinary skill m this art.
  • the DAC 302 receives digital signals directly from the control network 106, described below, on leads 115.
  • the DAC 302 converts a digital signal from either the computer 112 or the control network 106 into an analog amplification signal which is latched to a output line 304.
  • the magnitude of the output from a respective DAC 302 will determine the gain, or degree of amplification, of a particular RF amplifier 306.
  • the predetermined or fixed level output from the oscillator 104 is amplified by the variable gam provided by RF amplifier 306 with regard to the feedback ⁇ ignals from an associated electrode 202, 204 so that at least the desired operating parameter (e.g., power, voltage, or temperature) remains constant.
  • the desired operating parameter e.g., power, voltage, or temperature
  • a commercially available digitally controllable potentiometer such as a sixty-four b ⁇ t-256 step high-bandwidth potentiometer, can provide direct attenuation of the oscillator signal in respon ⁇ e to feedback ⁇ ignal ⁇ ⁇ ub ⁇ tantially a ⁇ described above instead of using the DAC 302.
  • the amplification signal on output line 304 is applied at an input of a RF amplifier 306.
  • the RF amplifier 306 additionally has a high-impedance input for receiving an analog signal from the oscillator 104.
  • the high impedance input of the RF amplifier 306 buffers the oscillator 104 from the load on its high-voltage output line 308, namely, the load pre ⁇ ented by one of electrodes 202, 204 before, during, and after an ablation procedure.
  • the RF amplifier provides clean amplification of the sine wave to a level sufficient to drive the electrodes 202, 204 during an ablation procedure, for example.
  • the oscillator 104 provides a relatively distortion free sine wave to each RF amplifier 306 connected to the power ⁇ upply arrangement 100, and the sine wave received by any one of the RF amplifiers 306 is m phase with the sine wave received by any other of the RF amplifier ⁇ 306 that may be connected to the power supply arrangement 100 through a module 110.
  • the output line 308 of the RF amplifier 306 connect ⁇ to the electrical lead 210 of a particular one of the electrodes 202, 204 via the conventional connector 214 (not ⁇ hown) .
  • the passive or return electrode which is dispo ⁇ ed on an extremity of the patient, is connected to the low-voltage (ground) output 310 of the RF amplifier 306, preferably through an electrical connection from the mother board 102 to ensure that each of the RF amplifiers 306 connected to the power supply arrangement 100 has a common ground.
  • the RF amplifier 306 includes sense output lines 311 so that the control network 106 can dynamically determine and monitor the resistance of the tissue being ablated and can responsively adjust the power, voltage, or temperature being delivered to the electrode.
  • the sense lines 311 include a voltage ⁇ ignal representative of the voltage which was applied to the electrode and a voltage signal representative of the current which passed through the tissue, as measured across a known, low resistance (e.g., 1 ⁇ ) This voltage sensing is accomplished in a preferred embodiment by RMS-to-DC converters which convert the detected peak voltage signals, after they have been suitably scaled for the RMS-to-DC converters .
  • the module 110 further has a signal sensor 312 which filters and amplifies, for example, a relatively low-voltage ⁇ ensed signals which would be continuously received from the temperature sensors 208 over line 314 assuming that the temperature sensors are thermocouples. If thermistors or RTDs were to be used, it l ⁇ understood that a wheatstone bridge or other circuitry would be provided to convert a sensed resistance into a voltage signal. In this manner, a clean, sensed voltage signal indicative of the temperature at a particular electrode is obtained and output on line 316
  • the input line 314 of the signal sensor 312 connects to the temperature sensor lead 216 of a particular one of the electrodes 202, 204 via a conventional connector 214 (not shown) .
  • the sensed signal on line 316 is dynamically processed by the control network 106, which, in turn, regulate ⁇ the power ⁇ upply 100 so as to maintain constant power, voltage, or temperature at the electrode from which the sensed signal was obtained.
  • a signal sensor 312 is provided for each temperature sensor 208.
  • a single signal sensor 312a may be associated with the temperature sensors 208 which are thermally associated with a different electrodes 202, 204 of the catheter 200 or other medical device, by circuitry configured to multiplex the outputs of several temperature sensor ⁇ 208 into the ⁇ ignal ⁇ en ⁇ or 312a Such an arrangement l ⁇ functionally identical to providing a signal sensor 312 for each electrode/temperature sensor pair.
  • the shared signal sensor 312a may be provided on the mother board 102 to reduce the number of components on any one module 110 (or module 110a, described next) .
  • FIG. 3 is configured to provide high- voltage output signals to a single ablation electrode on output line 308, and receive sensed signals from a temperature sensor 208 associated with the same electrode on input line 314.
  • four receptacles 108 are illustrated, each one adapted to receive a module 110.
  • four modules as in Fig. 3 can be plugged into the mother board 102 to enable the power, voltage, or temperature of four electrodes to be dynamically controlled, and the electrodes simultaneou ⁇ ly energized m pha ⁇ e with each other to achieve a de ⁇ ired lesion pattern.
  • the invention is not limited to the use of four such modules, as additional receptacles 108 may be provided for any desired number of electrodes.
  • each module 110 need not be limited to providing and receiving signal ⁇ from a single electrode/temperature sensor pair.
  • a modified module 110a is illustrated in which features common to Fig. 3 have been illustrated with corre ⁇ ponding reference numeral ⁇ .
  • a single module 110a permits signals to be simultaneously provided to and received from four electrode/temperature sensor pairs.
  • RF amplifier 306a can apply ablation energy over output line 308a in accordance with the amplification signals from the DAC 302a on its output line 304a, while RF amplifier 306b can simultaneously apply ablation energy over output line 308b according to the amplification signals it receives over line 304b just as if two modules 110 were plugged into separate receptacles 108 on the mother board 102.
  • the module 110a has input and output lines for two more electrodes.
  • a single module 110a plugged into a receptacle 108 can accommodate a ⁇ many electrodes a ⁇ four module ⁇ 110 (which would occupy all of the receptacle ⁇ 108 m Fig. 1) .
  • modules 110a were plugged into the four-receptacle arrangement of Fig. 1, then up to sixteen electrodes may be simultaneously energized and dynamically controlled. Combinations of modules 110 and 110a are also possible, as well a ⁇ the connection of module ⁇ having circuitry for additional or fewer electrode/temperature sensor pairs.
  • the mother board 102 preferably includes multi-pin receptacle ⁇ 108 which are adapted to receive modules that can accommodate between 1 and 10 electrode/temperature ⁇ en ⁇ or pairs Becau ⁇ e RF amplifiers 306 have high input impedance, an arbitrary number of RF amplifier ⁇ can be connected to the o ⁇ cillator 104, withm practical limits, to support a catheter with the same number of electrodes, with the RF energy being delivered to each of the electrodes phase with each other.
  • a modular power supply arrangement 100 l ⁇ provided which is expandable merely by inserting additional daughter board ⁇ or modules 110 into receptacles 108.
  • a basic module 110 can be inserted into each receptacle 108, or a more complex module 110a, etc can be inserted into one or more receptacle ⁇
  • circuitry sufficient for the intended catheter 200 or other medical device can be installed on an as-needed basis
  • older modules can be readily replaced or substituted with newer ones with great facility, when and as such improvements are made.
  • the control network 106 comprises a decision-based feedback loop which dynamically monitors the amplified and filtered sensed signals 316 from the temperature sensor 208 of a particular electrode, and provides signals to the DAC 302 for that electrode via line 115 which controls the degree of RF amplification by that electrode's RF amplifier 306
  • the control network 106 comprises a decision-based feedback loop which dynamically monitors the sense output lines 311 from the RMS-to-DC converters associated with a particular RF amplifier 306, and similarly provides control signal ⁇ on line 115 to control that electrode's RF amplifier 306
  • the control network 106 includes both software and hardware The software portions of the control network 106 can be implemented on the computer
  • the control network 106 clocks the output signal ⁇ 316 from the signal sensors 312 and from the RMS-to-DC converters on sense output lines 311 on board each module 110 as separate channels to an analog-to-digital converter (ADC) 502.
  • ADC analog-to-digital converter
  • These signals on lines 311, 316 comprise the operating parameters of the multipolar ablation device, for example, the catheter 200.
  • the clock (not shown) can run ⁇ ub ⁇ tantially fa ⁇ ter than the time constant of the system, which is limited by the speed of the temperature sensors and the tis ⁇ ue itself, the ADC 502 processes the signals 316 faster than they can change, which is effectively a continuous processing of the signal ⁇ from each of the electrode ⁇ of the ablation catheter 200 or other medical device.
  • the ADC 502 multiplexes these signals into a single digital data stream representative of each of the three detected voltage ⁇ for each electrode/temperature sensor pairs for further processing the digital domain.
  • the digital data are then processed by data processor 506 which determines the instantaneous tissue impedance R and temperature of the electrode at the temperature sen ⁇ or 208.
  • the instantaneous tissue impedance R is determined by dividing the sensed voltage applied to the electrode by the current through the electrode. This requires that the current through the electrode be calculated first.
  • This current is determined by the data processor 506 by dividing the voltage signal which is representative of the current that pas ⁇ ed through the tissue by the known resistance value, which value is retrievable, for example, from a computer-addressable data store such as data store 512
  • the true tissue impedance R is the result of these calculations after suitable scaling according to a calibrated scale, which may be readily determined for the particular device being used as understood by those of ordinary skill in this art
  • the instantaneous temperature is readily determined from the voltage signal from converted signal on the output line 504 of the ADC 502 If the temperature sensor 208 is a thermocouple, the temperature is linearly related to the sensed DC voltage accordmg to the particular characteristics of the device being used, which can be calibrated and which calibration can be stored m a data store, such as the data store 512 for use by the data processor 506, as understood by those skilled in the art If the temperature sensor 208 is a thermistor, then each increase/decrease in temperature is linearly related to each decrease/increase resistance, respectively.
  • the data processor 506 provides the determined tissue impedance R to a comparator 510, for example, along output lme 508.
  • the comparator compares the impedance R to data from a data store 512 to determine whether the impedance has risen abruptly, or whether it is greater than a pre ⁇ cribed threshold value.
  • a pre ⁇ cribed threshold value e.g. 200 ⁇ for a 4 mm electrode and approximately 400 to 500 ⁇ for a 2 mm electrode
  • the input lines to the DAC 302 for a particular electrode at which the impedance was measured are enabled, and a reduced magnitude drive signal can applied to the DAC 302 so that the magnitude of the amplification signal latched on the output lme 304 is reduced, whereby the ablation energy delivered to the electrodes on lme 308 is reduced.
  • the DAC 302 can be enabled by a direct addre ⁇ write, or by addressing it m conventional manner.
  • the particular impedance value at which coagulum formation might commence may be set by the operator or adjusted a program operating on a computer based on the identification of the particular catheter being used, or its operative characteristics (electrode length, electrode diameter, electrode spacing, electrode material, etc. ) .
  • comparator 510 is connected to lme 115 and can provide a reduced magnitude drive signal by decrementing the previous drive signal which may be stored in the data store 512 and enabling the input lines of the DAC 302 Alternatively, an increased magnitude drive signal can be applied to the electrodes if desired or necessary, for example, by incrementing the previous drive signal and enabling the input lines of the DAC 302.
  • the data proce ⁇ sor 506 provides the determined temperature to a comparator 514, for example, along output line 516.
  • the comparator compares the temperature to data , for example, the data store 512 to determine whether the temperature has risen abruptly, or whether it is greater than a prescribed threshold value.
  • a prescribed threshold value for example, 80° C
  • the ablation energy delivered to the electrodes on line 308 is reduced a ⁇ previou ⁇ ly described.
  • neither of these conditions are establi ⁇ hed, then either the previou ⁇ drive signal is reapplied to an enabled DAC 302, or no action s taken.
  • the power supply arrangement 100 is configurable at the computer console 112 in any one of a constant voltage, power, or temperature mode to provide energy for an ablation procedure to the catheter 200 or other medical device
  • the control network 106 continuously monitors and dynamically alters the power or voltage delivered or the temperature sensed at each of the electrodes, depending on the ⁇ elected mode, ⁇ o that the electrodes can be simultaneously energized yet be dynamically controlled so that the power, voltage, or operating temperature remains constant.
  • a user-set voltage is output to each of the electrodes 202, 204 and separately maintained throughout the ablation. This permits the operator to control the depth of lesion formation at each electrode and provides a vehicle for focusing the RF energy to produce a lesion that is, for instance, deeper at the proximal end than at the distal end.
  • this mode of operation permits a more uniform lesion to be produced, even if electrodes of different dimensions are being used, such as a 4 mm tip electrode 202 and 2mm ring electrodes 204. Electrodes of different dimensions, when driven with the same potential, will have differing power density distributions across them. Thus, the larger electrode will have a greater power density than the smaller electrode if driven at the same potential .
  • the power supply arrangement 100 accounts for these discrepancies in the constant voltage mode to permit a comparatively more uniform lesion profile than achievable in known present ablation catheter ⁇ ystems .
  • the tissue impedance R is dynamically monitored and the voltage applied to the electrodes 202, 204 varied with changes tissue impedance R to maintain a constant power level delivered at the site of each electrode.
  • lesions of arbitrary profile can be created.
  • Tissue impedance is monitored at the operating frequency of the sine wave oscillator 104. Because tissue impedance is typically higher than blood impedance, particularly in the 20 - 50 Khz range being used for sensing tissue contact, the sensed impedance data for each of the electrodes may be used to determine whether sufficiently conductive contact has been made between the electrodes and the myocardial wall.
  • the catheter can be repositioned in the event that one or more of the electrodes are determined to be less-than-desirable contact w th the myocardium.
  • the software executed on the computer 112 can be adapted to make this determination and to suggest catheter repositioning in response thereto, or this determination can be made by the operator after reviewing the impedance data on the screen of the computer console 112.
  • the present invention allows monitoring of the impedance and control of the energy delivery at each electrode to avoid this effect, or to terminate ablation at the tissue site of the electrode for which an impedance rise was detected.
  • the invention therefore permit ⁇ a single ablation of a larger area than possible w th a single electrode or multiple pole electrode catheter that lacks the inventive features de ⁇ cribed above, because several poles can be operated simultaneously without the inherent problems of a single large electrode.
  • the electrode temperature is dynamically monitored and the output voltage varied to maintain a constant, preset temperature.
  • a closed loop feedback system permits the voltage to each electrode to be dynamically controlled to maintain the temperature at a user-defined level.
  • any change in impedance due to tissue desiccation, blood coagulation, or charring at the electrode can be accommodated.
  • the comparator 514 outputs control signal ⁇ to the DAC 302 to manipulate the output power of the RF amplifier driving that electrode to maintain the sensed tissue temperature below the predetermined temperature.
  • the power supply arrangement 100 is configured in one of the constant voltage, power, or temperature modes. Then, radio-frequency energy in the range typically of about 250 Khz to 500 Khz is delivered simultaneously to each of the electrodes 202, 204. Energy flows from the catheter 200 through the tissue to a return plate, which is connected to ground via lme 310 and is positioned on the patient's skin, thereby completing the electrical circuit This flow of current to the tissue causes heating. The heating result ⁇ in the destruction of the tissue near the electrode, and ideally the arrhythmogenic site. If performed successfully, permanent interruption of the arrhythmia occurs and the patient is cured.
  • the control network 106 continuously monitors and dynamically controls either the power, voltage, or operating temperature of each of the electrodes, depending on the selected mode.
  • the operator can override, record, monitor, or otherwise supervise the procedure via computer console 112.
  • the electrode may be automatically deenergized, or it may ⁇ imply have the energy applied to it attenuated. Thi ⁇ prevents or reduces further delivery of RF power to that tissue site, while the remaining poles continue to deliver relatively greater amounts of RF energy. Thus, for example, if one portion of the endomyocardium is sufficiently heated to cause scarring, then only the surrounding tis ⁇ ue adjacent to the remaining pole ⁇ will have further energy applied.
  • the computer 112 has software loaded its memory which controls the system 100, for example, using the Microsoft Windows graphical user interface environment In this manner, a familiar interface is provided to the user which affords acces ⁇ to all of the functions needed to control the ablation system 100.
  • real-time monitoring of the ablation parameters can be displayed graphically for any one of the electrodes, a ⁇ de ⁇ cribed in U.S. Patent No. 5,233,515 to Cosman, the disclosure of which is incorporated by reference as if set forth fully herein, or for all of the electrodes of a ultipole catheter such as catheter 200, or some other medical device.
  • all of the data obtained during the procedure can be saved to disk for later retrieval and analysis. The data can be dynamically collected and displayed as well a ⁇ written to disk for later analysis.
  • An ablation system accordmg to another aspect of the mvention combines a multipole catheter such as catheter 200 or other medical device with the power supply arrangement 100 and a computer such as computer console 112.
  • a catheter has been constructed with its ring electrodes spaced 1 mm from each other and the tip electrode.
  • Empirical data has demonstrated that approximately 1 mm spacing of 2 mm long ring electrodes promotes the formation of a continuous lesion in the regions between the electrodes when the electrode ⁇ are simultaneou ⁇ ly energized using m-phase RF energy, without the abrupt temperature effects that have been observed when using electrodes that have been serially spaced over different lengths.
  • the 1 mm spacing thus results m an overlap of power density into the endomyocardial tissue linearly disposed between the serially spaced electrodes (202, 204) .
  • This electrode spacing is believed to produce the phenomenon of "charge crowding" which the localized impedance of that part of the electrode which is in proximity to another electrode (its edge) appears to be mcreased by the m-phase energy signal which is being concurrently applied to the adjacent electrodes. This appears to cause a reduction in the power density at the electrode's edge. In any event, a more uniform temperature distribution across the electrode has been observed. This is important because temperature sen ⁇ or ⁇ have conventionally been attached to the mid-point of an electrode to gauge its nominal temperature. Thus, such sen ⁇ or ⁇ have not measured the exponential rise in temperature which occurs at the electrode edges due to the rise m power density at the electrode edges. As a result, even m systems m which temperature monitoring of the electrodes has been used, blood coagulation and electrode fouling has occurred without the operator being informed of the significant elevation m overall temperature.
  • An ablation procedure using the foregoing ablation system reduces the time required to complete the treatment because the catheter 200 need only be placed in two or three different locations m the heart. All of the electrodes are energized for approximately one to two minutes. As compared to a sequentially firing method using a multiple pole catheter such as catheter 200, the treatment time is reduced by up to about thirteen minutes for each catheter placement, which may result in an overall time savings of more than one half hour m a typical ablation procedure. On the other hand, to create a continuous, linear lesion using a single electrode catheter, a number of individual lesions, on the order of forty-five lesions, are required. However, as much as five minutes may be required to position the tip electrode prior to firing it for about one minute. As a result, the lesion creating part of the procedure can be up to and over four hours, not including the requisite time to prepare the patient.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Plasma & Fusion (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Surgical Instruments (AREA)
  • Processing Of Solid Wastes (AREA)

Abstract

A radio-frequency ablation system is disclosed in which the power, voltage, or temperature delivered to multiple electrodes may be dynamically controlled, and in which the electrodes may be simultaneously energized in phase with each other to achieve a desired lesion pattern. The system comprises a multiple electrode ablation catheter, each electrode having a temperature sensor operatively associated therewith. Each electrode is energized by its own RF amplifier, and all of the electrodes are driven in phase with each other by a common sine wave oscillator. A feedback network controls the degree of amplification of the separate RF amplifiers. According to a further aspect of the invention, a modular power supply arrangement is disclosed which is configurable to dynamically control the power, voltage, or temperature delivered to multiple electrodes of a multipolar ablation device. An arbitrary number of electrodes may be simultaneously energized in phase with each other to achieve a desired lesion pattern using the modular power supply by providing a sufficient number of removable modules.

Description

RADIO FREQUENCY ENERGY DELIVERY SYSTEM FOR MULTIPOLAR ELECTRODE CATHETERS
Field of the Invention
This invention relates to electrode catheters and, m particular, to a power supply arrangement for simultaneously delivering single-phase energy to multiple electrodes of an electrode catheter.
Background of the Invention
Cardiac dysrhyth ias are commonly known as irregular heart beats or racing heart. Two such heart rhythm irregularities are the Wolff-Parkinson-White syndrome and AV nodal reentrant tachycardia. These conditions are caused by an extraneous strand of muscle fiber m the heart that provides an abnormal short-circuit pathway for electric impulses normally existing m the heart. For example, in one type of Wolff-Parkinson-White syndrome, the accessory pathway causes the electric impulses that normally travel from the upper to the lower chamber of the heart to be fed back to the upper chamber. Another common type of cardiac dysrhythmia is ventricular tachycardia (VT) , which may be a complication of a heart attack or reduction of blood supply to an area of heart muscle This latter type of cardiac dysrhythmia is a life- threatening arrhythmia
Atnal fibrillation (AF) is the most commonly occurring type of arrhythmia. It is associated w th increased morbidity and mortality due to a higher incidence of thromboembolic events and hemodynamic compromise. In patients with disabling drug resistant AF, the ventricular response can be controlled by catheter ablation or modification of the atrioventπcular (AV) nodal region, but this procedure is palliative since AF and ts related risks are persistent. Pacemakers may be used to prevent recurrence of paroxysmal AF by either preventing the sinus bradycardia that triggers AF or reducing the mteratrial conduction delay.
Non-surgical procedures such as management with drugs are favored in the treatment of cardiac dysrhythmias . However, some arrhythmias are not treatable with drugs, for example, disabling drug resistant AF, and have previously required surgery. According to these procedures, various incisions are made in the heart to block conduction pathways and thus divide the atrial area available for multiple wavelet reentry and abolish the arrhythmia. Alternatively, an Automatic Implantable Cardioverter/Defibrillator (AICD) can be surgically implanted into the patient, as described m U.S. Patent No. 4,817,608 to Shapland et al . While these surgical procedures can be curative, they are associated with increased morbidity and mortality rates, and are extremely expensive. Even the use of an AICD requires major surgical intervention. However, patients of advanced age or illness, for example, cannot tolerate invasive surgery to excise the tachycardia focus which causes dysrhythmias.
Non-surgical, minimally invasive techniques have been developed which are used to locate cardiac regions responsible for tachycardia, and also to disable the short-circuit function of these areas. According to these techniques, electrical energy shocks are applied to the endomyocardium to ablate cardiac tissue in the arrhythmogenic regions and produce scars which interrupt the reentrant conduction pathwayε. The regions to be ablated are usually first determined by endocardiac mapping techniques . Mapping typically involves percutaneously introducing an electrode catheter into the patient, passing the electrode catheter through a blood vessel (e.g. the femoral vein or aorta) and into an endocardiac site (e.g., the atrium or ventricle of the heart) , and inducing a tachycardia so that a continuous, simultaneous recording can be made with a multichannel recorder at each of several different endocardiac positions. When a tachycardial focus is located, as indicated in the electrocardiogram recording, it is marked by means of a fluoroscopic image so that cardiac arrhythmias at the located site can be ablated. A conventional electrode catheter provides electrical energy shocks to the tissue adjacent the electrode to create a lesion in the tissue. One or more suitably positioned lesions will create a region of necrotic tissue which will disable the malfunction caused by the tachycardial focus.
Conventional catheter ablation techniques have used catheters each having a single electrode fitted at its tip as one electrical pole. The other electrical pole is conventionally provided by a backplate in contact with a patient's external body part to form a capacitive coupling of the ablation energy source (DC, laser, RF, etc.) . Other ablation catheters are known in which multiple electrodes are provided, such as the catheters disclosed in U.S. Patents No.
5,239,999 to Imran, and 4,940,064 and 5,383,917, both to Desai .
Ablation is effected by applying energy to the catheter electrodes once the electrodes are in contact with the cardiac tissue. The energy can be, for example, RF, DC, ultrasound, microwave, or laser radiation. As between RF and DC ablation techniques, RF ablation is preferable because it does not require that the patient be anesthetized, and it produces more circumscribed and discrete lesions. Further, it avoids injury that may be caused by high voltages, for example, DC shock. When RF energy is delivered between the distal tip of a standard electrode catheter and a backplate, there is a localized RF heating effect. This creates a well-defined, discrete lesion slightly larger than the tip electrode. The small size of the lesions produced by RF ablation has been perceived as one of the limitations of this technique. Unless the electrode has a large contact region, the lesion created by the simple RF technique delivered through a standard electrode catheter may not be large enough to ablate enough tissue to block ventricular tachycardia, for example, because the electrode tip area is usually only about 0.3 mrr and the exit site of VT iε typically only locatable to within 4-8 cm2 of the earliest site recorded by the endocardiac mapping catheter. Also, attempts have been made to provide an elongated electrode six, eight, ten or even twelve millimeters in length to cause longer lesions, and to allow more power to be delivered to the tissue. However, flexibility of the tips of such catheters is reduced, and a stiffer catheter tip increases the risk of myocardial wall perforation, which in turn increases the morbidity rate of ablation procedures using such catheters.
Several other techniques have been implemented to produce larger and deeper lesions, including the use of different energy sources such as ultrasound, microwave, and laser. Other methods include using a saline-perfused catheter tip to cool the electrode/tissue interface, allowing more power to be delivered. One particular approach to increasing the size of the lesion is disclosed in U.S. Patent No. 4,940,064 to Desai. A retractable array of four orthogonal electrodes surrounds a central tip electrode and is powered by a conventional RF power source. This array was found to produce an unsatisfactory lesion pattern (in the form of a plus "+" sign) because substantial areas between the electrodes remained unablated, and the increase of power to the electrodes only resulted in charring of the tissues and early fouling of the electrodes by coagulum formation. As a solution, Desai et al . proposed in Patent No. 5,383,917 the use of a multi-phase power source to electrically drive the peripheral electrodes out of phase with respect to adjacent electrodes to create an electric potential between adjacent peripheral electrodes and thereby cause ablation in the regions between those adjacent electrodes (that is, lesions which connect the tips of the plus "+" pattern to one another) . This solution dispenses with the uεe of an external return or passive electrode because ground potential is provided at the central tip electrode, but poses constraints on the dimensions of the electrodes for satisfactory operation, and does not produce a continuous, linear lesion among or between the electrodes. See col. 8, lines 19-30 of 5,383,917. In another approach, a serieε of electrodes were arranged along a catheter shaft to demonstrate the feasibility of catheter ablation of typical human AF by the sequential application of radiofrequency energy m a system using a backplate Haissaguerre, et al . , "Successful Ca theter Abla tion of Atnal Fibrilla tion , " J. Cardiovascular El ectrophysiol ogy , 1994 , Vol . 12 , No . 5 : 1045 -1052 . While the investigators in this study cured the AF m the patient, they were unable to confirm whether the lesions produced at the site of each electrode oined together to form a continuous lesion
What is needed in the art and has heretofore not been available is a power supply arrangement for independently and controllably driving a multiplicity of electrodes spaced along the distal end of a cardiac ablation catheter Also needed m the art lε an ablation system which incorporates such a power supply arrangement with an ablation catheter so that continuous, linear ablation lesions of a predetermined contour can be formed m the endomyocardium
Obiects of the Invention
Accordingly, it is a general object of the present invention to improve catheter ablations.
It is an object of the present invention to improve cardiac catheter ablations.
It is also an object of the present invention to improve power supplies for use m catheter ablation procedures. It is another object of the present invention to control the contour of lesions created by RF catheter ablations including both the length and depth of such lesions
It is yet another object of the present invention to improve the efficiency of RF catheter ablation procedures. It is yet another object of the present invention to treat ventricular tachycardia by improved RF catheter ablationε
It lε yet a further object of the present invention to treat atrial fibrillation by improved RF catheter ablations These and other objectε are accomplished by simultaneous, parallel application of a single-phase RF power source to multiple poles of an electrode catheter such that the voltage, power, or temperature can be controlled as the ablation procedure proceeds Summary of the Invention
According to one aspect of the invention, a raαio- frequency ablation syεtem for biological tissues is provided in which the power, voltage, or temperature delivered to multiple electrodes may be dynamically controlled, and m which the electrodes may be simultaneously energized in phase with each other to achieve a deεired lesion pattern The εyεtem compriseε an electrode catheter having a generally longitudinally extending shaft which defines a lumen, and an array of externally conductive, individually connected electrodeε arranged in spaced serial relation along the shaft The electrode catheter further comprises a plurality of temperature sensors each of which is thermally associated with a different electrode m the array to provide a temperature signal representative of the temperature of that electrode A plurality of RF amplifiers are electrically connected to different electrodes in the array. Each RF amplifier provides drive signals representative of the voltage and current applied to the electrode to which it is connected A feedback control network is provided with these drive signalε along with the temperature signal for the same electrode, m response to the received temperature and drive εignalε of a particular electrode, the feedback control network provides an amplification signal to each RF amplifier Also, a RF sine wave oscillator, which has an output that is separately amplified in phase by each of the RF amplifiers m accordance with the amplification signal from the feedback control network for that RF amplifier, is also provided to independently drive each of the electrodes in the array of electrodes m phase with each other.
According to another aεpect of the invention, a modular power supply arrangement for a rnultipolar ablation device is provided. The modular power supply arrangement comprises a mother board including one or more receptacles adapted to receive a module, a sine wave oscillator which has an output electrically connected to the receptacle, and a feedback control network which (1) receives input signals from the module m the receptacle, (2) processes the input signals, and (3) provides an amplification signal which is responsive to the input signals to that nodule The modular power supply arrangement further comprises at least one module removably connected to the receptacle. In its simplest form, the module includeε a RF amplifier for driving a particular pole of the multipolar ablation device in phaεe with the oscillator output in accordance with the amplification signal from the feedback control network, and a signal sensor for sensing predetermined operating parameters of the particular pole of the multipolar ablation device and providing the input signalε to the feedback control network. Two or more εuch modules are used to energize multiple electrodes. Multiple electrodes are controlled by the modular power supply arrangement when multiple receptacles are provided, or when modules which are configured to energize multiple electrodes are provided, or both. According to one modification of the invention, the module may be configured with multiple RF amplifiers, each driving a different pole of a multipolar ablation device m phase with the sine wave oscillator output and m accordance with the amplification signal from the feedback control network. Further, each module according to this modification is configured with a plurality of signal sensors for sensing predetermined operating parameters of the multipolar ablation device and providing the input εignalε to the feedback control network.
Deεcription of the Drawings Fig. 1 schematically illustrates a RF power supply arrangement for an ablation catheter according to the invention;
Fig. 2 is a diagrammatic view of the distal end of an ablation catheter which is carrying multiple electrodes and temperature sensors;
Fig. 3 s a detailed schematic illustration of a module for insertion into the power supply arrangement of Fig
1, the module being adapted for use with a single electrode, Fig. 4 iε a detailed schematic illustration of a modified module for insertion into the power supply arrangement of Fig. 1, the modified module being adapted for use with four electrodes; and Fig. 5 is a detailed schematic illustration of the control network of Fig. 1.
Detailed Description of the Preferred Embodiments
By way of overview and introduction, there is seen in Fig. 1 a schematic illustration of a power supply arrangement 100 according to the present invention which is adapted to maintain constant power, voltage, or temperature at each electrode of a multielectrode catheter. Arrangement 100 is preferably constructed on a mother board 102 and includes a sine wave oscillator 104, a control network 106, and a plurality of receptacleε 108 adapted to receive plug-in daughter boards or modules 110. Each daughter board 110 is computer addressable over a bidirectional data and addreεs buε 114, and containε feedback loop control circuitry for individually maintaining one or more electrodeε at a constant power, voltage, or temperature. A computer 112 operatively attached to and in signal communication with the bus 114 preferably includes operating software which is adapted to provide control signals to the modules 110 for individually controlling the electrodes of a multielectrode catheter. The computer 112 also preferably includes appropriate input/output features and εoftware for dynamically diεplaying the current, time, voltage, power, temperature, or impedance of the individual electrodes, or displaying other signalε such as electrocardiograms (EKGs) .
The sine wave oεcillator 104 on the mother board provides a predetermined frequency drive signal in the range of 20 to 500 Khz to each of the oduleε 110 εo that each of the RF amplifierε, which are part of the moduleε 110, m the power supply arrangement 100 iε driven in phase with the others. The lower end of the drive signal range (that is, about 20 - 50 Khz) is conventionally used at a relatively low-amplitude level to determine catheter contact with the endocardium without stimulating the heart as contact measurements are being made At higher frequencieε, the heart is not stimulated at the amplitudes used in the ablation procedure.
The power supply arrangement 100 of Fig. 1 has utility, for example, with medical devices such as catheter 200, the distal end of which is illustrated m Fig. 2 The catheter 200 is an ablation catheter configured with multiple electrodes, serially spaced in an axial direction along the catheter. The catheter 200 is conventionally constructed of an insulative, biocompatable tubing material, and has an outside diameter small enough to pasε through a vascular system from an introducer site to a desired cardiac chamber, and has the capability to negotiate the vascular system In other words, it is sufficiently flexible to be advanced through a tortuous vasculature, yet possesses sufficient column strength to permit its advancement therethrough
The catheter 200 has a tip electrode 202 which occupies the distal 2-4 mm of the catheter. Conventionally, the tip electrode 202 is made of platinum and is attached directly to the distal end of the catheter 200. Alternatively, a refractive material (not shown) may be interposed between the tip electrode 202 (or the other electrodes) and the catheter 200 to prevent melting of the supporting catheter during and just after ablation energy haε been applied to the electrode In addition, the catheter 200 haε externally conductive ring electrodeε 204 εpaced therealong in serial manner Three ring electrodes 204 are illustrated in Fig. 2, however, the catheter 200 can have an arbitrarily large number of electrodes. For example, Dr. Michel Haissaguerre haε proposed a catheter construction for AF treatment which has thirteen ring electrodes 204 and a single tip electrode 202 The ring electrodeε 204 are spaced from each other (and the tip electrode 202) by insulative regions 206, and each can be of an arbitrary axial length. Presently, they are preferably approximately 2 mm in axial length. While the ring electrodes 204 can be spaced 1 - 3 mm apart, as described m more detail below m connection with an ablation system according to the invention, it is presently preferred that they be spaced 1 mm apart .
Each electrode 202, 204 has a separate conductive lead 210 attached thereto which extends proximally through at least one lumen 212 in the catheter 200 to a connector 214 (not shown) . Also, associated with each electrode 202, 204 is a temperature sensor 208 disposed adjacent the electrode for providing an electrical signal indicative of the temperature of the electrode. The temperature sensor 208 can be a thermocouple, thermistor, or resistive thermal device ("RTD") . Each temperature sensor 208 has a conductive lead 216 attached to it which extends proximally to the connector 214. A cable 218 (not shown) houses the electrode and temperature sensor leads 210, 216 between the proximal end of the catheter 200 and the connector 214. The connector mates with a terminal on the module 110.
With reference now to Fig. 3, the circuitry m each module 110 is described.
The module 110 communicates with the computer 112 via the two-way bus 114 via an electrical connection between the module 110 and the receptacle 108 of the mother board 102. A digital-to-analog converter (DAC) 302 is arranged in conventional manner to be addressed by the computer 112, as will be readily understood by those of ordinary skill m this art. In addition, the DAC 302 receives digital signals directly from the control network 106, described below, on leads 115. The DAC 302 converts a digital signal from either the computer 112 or the control network 106 into an analog amplification signal which is latched to a output line 304. The magnitude of the output from a respective DAC 302 will determine the gain, or degree of amplification, of a particular RF amplifier 306. The predetermined or fixed level output from the oscillator 104 is amplified by the variable gam provided by RF amplifier 306 with regard to the feedback εignals from an associated electrode 202, 204 so that at least the desired operating parameter (e.g., power, voltage, or temperature) remains constant. There are other functionally equivalent ways of providing an unfaltering control εignal to the RF amplifier 306, the use of the DAC 302 being merely illustrative of a presently preferred arrangement. For example, a commercially available digitally controllable potentiometer, such as a sixty-four bιt-256 step high-bandwidth potentiometer, can provide direct attenuation of the oscillator signal in responεe to feedback εignalε εubεtantially aε described above instead of using the DAC 302.
The amplification signal on output line 304 is applied at an input of a RF amplifier 306. The RF amplifier 306 additionally has a high-impedance input for receiving an analog signal from the oscillator 104. The high impedance input of the RF amplifier 306 buffers the oscillator 104 from the load on its high-voltage output line 308, namely, the load preεented by one of electrodes 202, 204 before, during, and after an ablation procedure. The RF amplifier provides clean amplification of the sine wave to a level sufficient to drive the electrodes 202, 204 during an ablation procedure, for example. On the other hand, the oscillator 104 provides a relatively distortion free sine wave to each RF amplifier 306 connected to the power εupply arrangement 100, and the sine wave received by any one of the RF amplifiers 306 is m phase with the sine wave received by any other of the RF amplifierε 306 that may be connected to the power supply arrangement 100 through a module 110. The output line 308 of the RF amplifier 306 connectε to the electrical lead 210 of a particular one of the electrodes 202, 204 via the conventional connector 214 (not εhown) . The passive or return electrode, which is dispoεed on an extremity of the patient, is connected to the low-voltage (ground) output 310 of the RF amplifier 306, preferably through an electrical connection from the mother board 102 to ensure that each of the RF amplifiers 306 connected to the power supply arrangement 100 has a common ground.
Further, the RF amplifier 306 includes sense output lines 311 so that the control network 106 can dynamically determine and monitor the resistance of the tissue being ablated and can responsively adjust the power, voltage, or temperature being delivered to the electrode. The sense lines 311 include a voltage εignal representative of the voltage which was applied to the electrode and a voltage signal representative of the current which passed through the tissue, as measured across a known, low resistance (e.g., 1 Ω) This voltage sensing is accomplished in a preferred embodiment by RMS-to-DC converters which convert the detected peak voltage signals, after they have been suitably scaled for the RMS-to-DC converters .
The module 110 further has a signal sensor 312 which filters and amplifies, for example, a relatively low-voltage εensed signals which would be continuously received from the temperature sensors 208 over line 314 assuming that the temperature sensors are thermocouples. If thermistors or RTDs were to be used, it lε understood that a wheatstone bridge or other circuitry would be provided to convert a sensed resistance into a voltage signal. In this manner, a clean, sensed voltage signal indicative of the temperature at a particular electrode is obtained and output on line 316 The input line 314 of the signal sensor 312 connects to the temperature sensor lead 216 of a particular one of the electrodes 202, 204 via a conventional connector 214 (not shown) . The sensed signal on line 316 is dynamically processed by the control network 106, which, in turn, regulateε the power εupply 100 so as to maintain constant power, voltage, or temperature at the electrode from which the sensed signal was obtained.
Preferably, a signal sensor 312 is provided for each temperature sensor 208. However, a single signal sensor 312a may be associated with the temperature sensors 208 which are thermally associated with a different electrodes 202, 204 of the catheter 200 or other medical device, by circuitry configured to multiplex the outputs of several temperature sensorε 208 into the εignal εenεor 312a Such an arrangement lε functionally identical to providing a signal sensor 312 for each electrode/temperature sensor pair. Further, the shared signal sensor 312a may be provided on the mother board 102 to reduce the number of components on any one module 110 (or module 110a, described next) . The module of Fig. 3 is configured to provide high- voltage output signals to a single ablation electrode on output line 308, and receive sensed signals from a temperature sensor 208 associated with the same electrode on input line 314. In the power supply arrangement of Fig. 1, four receptacles 108 are illustrated, each one adapted to receive a module 110. Thus, four modules as in Fig. 3 can be plugged into the mother board 102 to enable the power, voltage, or temperature of four electrodes to be dynamically controlled, and the electrodes simultaneouεly energized m phaεe with each other to achieve a deεired lesion pattern. The invention is not limited to the use of four such modules, as additional receptacles 108 may be provided for any desired number of electrodes.
Further, each module 110 need not be limited to providing and receiving signalε from a single electrode/temperature sensor pair. With reference now to Fig. 4, a modified module 110a is illustrated in which features common to Fig. 3 have been illustrated with correεponding reference numeralε. When inserted into the mother board 102, a single module 110a permits signals to be simultaneously provided to and received from four electrode/temperature sensor pairs. Thuε, RF amplifier 306a can apply ablation energy over output line 308a in accordance with the amplification signals from the DAC 302a on its output line 304a, while RF amplifier 306b can simultaneously apply ablation energy over output line 308b according to the amplification signals it receives over line 304b just as if two modules 110 were plugged into separate receptacles 108 on the mother board 102. However, the module 110a has input and output lines for two more electrodes. Thus, a single module 110a plugged into a receptacle 108 can accommodate aε many electrodes aε four moduleε 110 (which would occupy all of the receptacleε 108 m Fig. 1) . If four modules 110a were plugged into the four-receptacle arrangement of Fig. 1, then up to sixteen electrodes may be simultaneously energized and dynamically controlled. Combinations of modules 110 and 110a are also possible, as well aε the connection of moduleε having circuitry for additional or fewer electrode/temperature sensor pairs. The mother board 102 preferably includes multi-pin receptacleε 108 which are adapted to receive modules that can accommodate between 1 and 10 electrode/temperature εenεor pairs Becauεe RF amplifiers 306 have high input impedance, an arbitrary number of RF amplifierε can be connected to the oεcillator 104, withm practical limits, to support a catheter with the same number of electrodes, with the RF energy being delivered to each of the electrodes phase with each other.
According to an aspect of the invention, a modular power supply arrangement 100 lε provided which is expandable merely by inserting additional daughter boardε or modules 110 into receptacles 108. A basic module 110 can be inserted into each receptacle 108, or a more complex module 110a, etc can be inserted into one or more receptacleε By this arrangement, circuitry sufficient for the intended catheter 200 or other medical device can be installed on an as-needed basis Further, older modules can be readily replaced or substituted with newer ones with great facility, when and as such improvements are made. Each RF amplifier provides a fixed level of amplification based on the magnitude of the amplification signal latched onto the output line 304 of the DAC 302 The amplification signal latched onto output line 304 at any moment can originate either at the computer console 112 or the control network 106, shown in greater detail in Fig 5 The control network 106 comprises a decision-based feedback loop which dynamically monitors the amplified and filtered sensed signals 316 from the temperature sensor 208 of a particular electrode, and provides signals to the DAC 302 for that electrode via line 115 which controls the degree of RF amplification by that electrode's RF amplifier 306 Likewise, the control network 106 comprises a decision-based feedback loop which dynamically monitors the sense output lines 311 from the RMS-to-DC converters associated with a particular RF amplifier 306, and similarly provides control signalε on line 115 to control that electrode's RF amplifier 306 In the preferred embodiment, the control network 106 includes both software and hardware The software portions of the control network 106 can be implemented on the computer 112
The control network 106 clocks the output signalε 316 from the signal sensors 312 and from the RMS-to-DC converters on sense output lines 311 on board each module 110 as separate channels to an analog-to-digital converter (ADC) 502. These signals on lines 311, 316 comprise the operating parameters of the multipolar ablation device, for example, the catheter 200. Because the clock (not shown) can run εubεtantially faεter than the time constant of the system, which is limited by the speed of the temperature sensors and the tisεue itself, the ADC 502 processes the signals 316 faster than they can change, which is effectively a continuous processing of the signalε from each of the electrodeε of the ablation catheter 200 or other medical device. The ADC 502 multiplexes these signals into a single digital data stream representative of each of the three detected voltageε for each electrode/temperature sensor pairs for further processing the digital domain. The digital data are then processed by data processor 506 which determines the instantaneous tissue impedance R and temperature of the electrode at the temperature senεor 208. The instantaneous tissue impedance R is determined by dividing the sensed voltage applied to the electrode by the current through the electrode. This requires that the current through the electrode be calculated first. This current is determined by the data processor 506 by dividing the voltage signal which is representative of the current that pasεed through the tissue by the known resistance value, which value is retrievable, for example, from a computer-addressable data store such as data store 512 The true tissue impedance R is the result of these calculations after suitable scaling according to a calibrated scale, which may be readily determined for the particular device being used as understood by those of ordinary skill in this art The instantaneous temperature is readily determined from the voltage signal from converted signal on the output line 504 of the ADC 502 If the temperature sensor 208 is a thermocouple, the temperature is linearly related to the sensed DC voltage accordmg to the particular characteristics of the device being used, which can be calibrated and which calibration can be stored m a data store, such as the data store 512 for use by the data processor 506, as understood by those skilled in the art If the temperature sensor 208 is a thermistor, then each increase/decrease in temperature is linearly related to each decrease/increase resistance, respectively. Again, the particular thermistor under consideration can be calibrated and the calibration data can be stored the data store 512. The data processor 506 provides the determined tissue impedance R to a comparator 510, for example, along output lme 508. The comparator compares the impedance R to data from a data store 512 to determine whether the impedance has risen abruptly, or whether it is greater than a preεcribed threshold value. Aε understood by those skilled the art, when tissue impedance exceeds a predetermined value which depends on the length of the electrode and whether the electrodes are being driven simultaneously (e.g. 200 Ω for a 4 mm electrode and approximately 400 to 500 Ω for a 2 mm electrode) , there may be blood coagulation or protein deposits on the electrode. Conventional RF ablation schemes produce early impedance rises at the power supply due to efficient necrosiε of tissues and possibly early coagulum formation at the electrodes. The formation of coagulum has the effect of restricting the current flow through the endomyocardium and limiting the depth of lesion formation therein. When coagulation begins, the impedance tends to rise abruptly above the predetermined value for the chosen electrode length. Accordingly, if the tissue impedance R has either risen abruptly or surpasεed a prescribed threshold value, for example, 400 Ω, then the input lines to the DAC 302 for a particular electrode at which the impedance was measured are enabled, and a reduced magnitude drive signal can applied to the DAC 302 so that the magnitude of the amplification signal latched on the output lme 304 is reduced, whereby the ablation energy delivered to the electrodes on lme 308 is reduced. The DAC 302 can be enabled by a direct addreεε write, or by addressing it m conventional manner. On the other hand, if neither of these conditions are establiεned, then either the previous drive εignal lε reapplied to an enabled DAC 302, or no action lε taken. The particular impedance value at which coagulum formation might commence may be set by the operator or adjusted a program operating on a computer based on the identification of the particular catheter being used, or its operative characteristics (electrode length, electrode diameter, electrode spacing, electrode material, etc. ) .
The output of comparator 510 is connected to lme 115 and can provide a reduced magnitude drive signal by decrementing the previous drive signal which may be stored in the data store 512 and enabling the input lines of the DAC 302 Alternatively, an increased magnitude drive signal can be applied to the electrodes if desired or necessary, for example, by incrementing the previous drive signal and enabling the input lines of the DAC 302.
Similarly, the data proceεsor 506 provides the determined temperature to a comparator 514, for example, along output line 516. The comparator compares the temperature to data , for example, the data store 512 to determine whether the temperature has risen abruptly, or whether it is greater than a prescribed threshold value. One manner of alleviating the problem of early coagulum formation at the electrodes is by closely regulating the ablation temperature to just below approximately 80°C. This also helps to produce larger and deeper lesions with more uniformity. Accordingly, if the temperature has either risen abruptly or surpasεed a prescribed threshold value, for example, 80° C, then the ablation energy delivered to the electrodes on line 308 is reduced aε previouεly described. On the other hand, if neither of these conditions are establiεhed, then either the previouε drive signal is reapplied to an enabled DAC 302, or no action s taken.
In operation, the power supply arrangement 100 is configurable at the computer console 112 in any one of a constant voltage, power, or temperature mode to provide energy for an ablation procedure to the catheter 200 or other medical device The control network 106 continuously monitors and dynamically alters the power or voltage delivered or the temperature sensed at each of the electrodes, depending on the εelected mode, εo that the electrodes can be simultaneously energized yet be dynamically controlled so that the power, voltage, or operating temperature remains constant.
In the constant voltage mode, a user-set voltage is output to each of the electrodes 202, 204 and separately maintained throughout the ablation. This permits the operator to control the depth of lesion formation at each electrode and provides a vehicle for focusing the RF energy to produce a lesion that is, for instance, deeper at the proximal end than at the distal end. Alternatively, this mode of operation permits a more uniform lesion to be produced, even if electrodes of different dimensions are being used, such as a 4 mm tip electrode 202 and 2mm ring electrodes 204. Electrodes of different dimensions, when driven with the same potential, will have differing power density distributions across them. Thus, the larger electrode will have a greater power density than the smaller electrode if driven at the same potential . However, the power supply arrangement 100 accounts for these discrepancies in the constant voltage mode to permit a comparatively more uniform lesion profile than achievable in known present ablation catheter εystems .
In the constant power mode, the tissue impedance R is dynamically monitored and the voltage applied to the electrodes 202, 204 varied with changes tissue impedance R to maintain a constant power level delivered at the site of each electrode. As in the constant voltage mode, lesions of arbitrary profile can be created. Tissue impedance is monitored at the operating frequency of the sine wave oscillator 104. Because tissue impedance is typically higher than blood impedance, particularly in the 20 - 50 Khz range being used for sensing tissue contact, the sensed impedance data for each of the electrodes may be used to determine whether sufficiently conductive contact has been made between the electrodes and the myocardial wall. The catheter can be repositioned in the event that one or more of the electrodes are determined to be less-than-desirable contact w th the myocardium. The software executed on the computer 112 can be adapted to make this determination and to suggest catheter repositioning in response thereto, or this determination can be made by the operator after reviewing the impedance data on the screen of the computer console 112.
It is noteworthy that there may be a rise the tissue impedance R adjacent the more proximal electrodes on the catheter 200 as compared to the more distal electrodes. This is not detectable by overall tisεue impedance meaεurementε which treat each electrode aε a separate impedance m parallel with the other electrodes and thereby aεkε the individual impedanceε at each electrode. Therefore, an impedance riεe at one of these electrodes would not result an overall rise of the parallel impedances. Neverthelesε, this impedance rise could cause adhesion of the catheter to myocardial tissue that could be hazardous. However, the present invention allows monitoring of the impedance and control of the energy delivery at each electrode to avoid this effect, or to terminate ablation at the tissue site of the electrode for which an impedance rise was detected. The invention therefore permitε a single ablation of a larger area than possible w th a single electrode or multiple pole electrode catheter that lacks the inventive features deεcribed above, because several poles can be operated simultaneously without the inherent problems of a single large electrode.
Finally, in the constant temperature mode, the electrode temperature is dynamically monitored and the output voltage varied to maintain a constant, preset temperature. A closed loop feedback system permits the voltage to each electrode to be dynamically controlled to maintain the temperature at a user-defined level. Thus, any change in impedance due to tissue desiccation, blood coagulation, or charring at the electrode can be accommodated. As a direct result of maintaining the site temperature such that there is no blood coagulation, the potential for thrombus formation or the adhesion of the catheter to the myocardium is reduced. If an undesired temperature is detected at the electrode, the comparator 514 outputs control signalε to the DAC 302 to manipulate the output power of the RF amplifier driving that electrode to maintain the sensed tissue temperature below the predetermined temperature. Meanwhile, the RF voltage delivered to the remaining electrodes remains unaffected. In operation, once the arrhythmogenic site is determmed, the power supply arrangement 100 is configured in one of the constant voltage, power, or temperature modes. Then, radio-frequency energy in the range typically of about 250 Khz to 500 Khz is delivered simultaneously to each of the electrodes 202, 204. Energy flows from the catheter 200 through the tissue to a return plate, which is connected to ground via lme 310 and is positioned on the patient's skin, thereby completing the electrical circuit This flow of current to the tissue causes heating. The heating resultε in the destruction of the tissue near the electrode, and ideally the arrhythmogenic site. If performed successfully, permanent interruption of the arrhythmia occurs and the patient is cured.
The control network 106 continuously monitors and dynamically controls either the power, voltage, or operating temperature of each of the electrodes, depending on the selected mode. The operator can override, record, monitor, or otherwise supervise the procedure via computer console 112.
If any of the electrode conditions exceeds a user defined impedance or temperature limit, or if impedance or temperature rise too rapidly, the electrode may be automatically deenergized, or it may εimply have the energy applied to it attenuated. Thiε prevents or reduces further delivery of RF power to that tissue site, while the remaining poles continue to deliver relatively greater amounts of RF energy. Thus, for example, if one portion of the endomyocardium is sufficiently heated to cause scarring, then only the surrounding tisεue adjacent to the remaining poleε will have further energy applied.
Preferably, the computer 112 has software loaded its memory which controls the system 100, for example, using the Microsoft Windows graphical user interface environment In this manner, a familiar interface is provided to the user which affords accesε to all of the functions needed to control the ablation system 100. Also, real-time monitoring of the ablation parameters can be displayed graphically for any one of the electrodes, aε deεcribed in U.S. Patent No. 5,233,515 to Cosman, the disclosure of which is incorporated by reference as if set forth fully herein, or for all of the electrodes of a ultipole catheter such as catheter 200, or some other medical device. Further, all of the data obtained during the procedure can be saved to disk for later retrieval and analysis. The data can be dynamically collected and displayed as well aε written to disk for later analysis.
An ablation system accordmg to another aspect of the mvention combines a multipole catheter such as catheter 200 or other medical device with the power supply arrangement 100 and a computer such as computer console 112. A catheter has been constructed with its ring electrodes spaced 1 mm from each other and the tip electrode. Empirical data has demonstrated that approximately 1 mm spacing of 2 mm long ring electrodes promotes the formation of a continuous lesion in the regions between the electrodes when the electrodeε are simultaneouεly energized using m-phase RF energy, without the abrupt temperature effects that have been observed when using electrodes that have been serially spaced over different lengths. The 1 mm spacing thus results m an overlap of power density into the endomyocardial tissue linearly disposed between the serially spaced electrodes (202, 204) .
This electrode spacing is believed to produce the phenomenon of "charge crowding" which the localized impedance of that part of the electrode which is in proximity to another electrode (its edge) appears to be mcreased by the m-phase energy signal which is being concurrently applied to the adjacent electrodes. This appears to cause a reduction in the power density at the electrode's edge. In any event, a more uniform temperature distribution across the electrode has been observed. This is important because temperature senεorε have conventionally been attached to the mid-point of an electrode to gauge its nominal temperature. Thus, such senεorε have not measured the exponential rise in temperature which occurs at the electrode edges due to the rise m power density at the electrode edges. As a result, even m systems m which temperature monitoring of the electrodes has been used, blood coagulation and electrode fouling has occurred without the operator being informed of the significant elevation m overall temperature.
An ablation procedure using the foregoing ablation system reduces the time required to complete the treatment because the catheter 200 need only be placed in two or three different locations m the heart. All of the electrodes are energized for approximately one to two minutes. As compared to a sequentially firing method using a multiple pole catheter such as catheter 200, the treatment time is reduced by up to about thirteen minutes for each catheter placement, which may result in an overall time savings of more than one half hour m a typical ablation procedure. On the other hand, to create a continuous, linear lesion using a single electrode catheter, a number of individual lesions, on the order of forty-five lesions, are required. However, as much as five minutes may be required to position the tip electrode prior to firing it for about one minute. As a result, the lesion creating part of the procedure can be up to and over four hours, not including the requisite time to prepare the patient.
Having thus described preferred embodiments of the present invention, it is to be understood that the above described arrangement and system is merely illustrative of the principles of the present invention, and that other arrangements and syεtems may be deviεed by those skilled in the art without departing from the spirit and scope of the invention as claimed below.

Claims

I Claim : 1. A radio-frequency ablation system for biological tissueε, comprising: an electrode catheter having a generally longitudinally extending shaft defining a lumen and an array of externally conductive, individually connected electrodes arranged in spaced serial relation along εaid shaft; a plurality of temperature sensors, each thermally associated with a different electrode in said array for providing a temperature signal representative of the temperature of that electrode; a plurality of RF amplifiers, each electrically connected to a different electrode in said array, each of said RF amplifiers providing drive signals representative of the voltage and current applied to that electrode; a feedback control network which receives said temperature and drive εignalε associated with a particular electrode and provides an amplification signal to the RF amplifier connected to that electrode in response to the received temperature and drive signals; and a RF sine wave oscillator having an output which is εeparately amplified in phaεe by each of εaid RF amplifierε in accordance with the amplification signal from the feedback control network for that RF amplifier, to independently drive each of the electrodes in the array of electrodes in phase with each other.
2. The radio-frequency ablation system as in claim 1, wherein each of the electrodes in said array of electrodes is driven simultaneously at differing levels of amplification.
3. The radio-frequency ablation system as in claim 1, wherein said feedback control network returns an amplification signal to maintain the temperature of an electrode constant .
4. The radio-frequency ablation syεtem aε in claim 1, wherein said feedback control network returns an amplification signal to maintain the power through an electrode constant .
5. The radio-frequency ablation system as in claim 1, wherein said feedback control network returns an amplification signal to maintain the voltage through an electrode constant .
6. The radio-frequency ablation system as in claim 1, wherein said electrodes are spaced such that the power delivered to adjacent electrodes spans the tissue between said adjacent electrodes sufficient to cause a continuous lesion to form.
7. The radio-frequency ablation syεtem as m claim 1, wherein successive adjacent electrodes in said array are spaced at different predetermined distances.
8. The radio-frequency ablation syεtem aε in claim 1, further compriεing a return electrode connected to a ground potential output of εaid RF amplifiers.
9. The radio-frequency ablation system as in claim 1, wherein one of said electrodes in said array is disposed at the catheter distal tip, and the remaining electrodes in said array are ring electrodes surrounding said shaft .
10. The radio-frequency ablation system as m claim 1, wherein said temperature sensor is one of a thermocouple, thermistor, or resistive thermal device.
11. A modular power supply arrangement for a multipolar ablation device, comprising: a mother board including- a receptacle adapted to receive a module, a sine wave oscillator which has an output electrically connected to said receptacle, and a feedback control network which receives input signals from the module m said receptacle, processes the input signals, and provides an amplification signal to that module which amplification signal is responεive to the input signals; and at least one module removably connected to said receptacle, said module including: at least two RF amplifiers, each of said RF amplifiers driving a different pole of the multipolar ablation device m phase with the oscillator output in accordance with the amplification signal from the feedback control network, and a plurality of signal sensors for sensmg predetermined operating parameters of the multipolar ablation device and providing the mput signalε to the feedback control network, the plurality of signal processors being functionally equal in number to said RF amplifiers.
12. The modular power supply arrangement as m claim 11, further comprising a plurality of receptacleε.
13 A modular power εupply arrangement for a multipolar ablation device, comprising: a mother board including: a plurality of receptacles each being adapted to receive a module, a sine wave oscillator which has an output electrically connected to each of said receptacles, and a feedback control network which receives input signalε from the module in a respective receptacle, processes the input signalε, and provides an amplification signal to that module which amplification signal is responsive to the input signalε; and at leaεt two moduleε removably connected to εaid receptacleε, each of εaid modules including- a RF amplifier for driving a particular pole of the multipolar ablation device phase with said oscillator output in accordance with the amplification signal from the feedback control network, and a signal sensor for sensing predetermined operating parameters of said particular pole of the multipolar ablation device and providing the input signals to the feedback control network.
14. The modular power supply arrangement as in claim 13, wherein each of said at least two modules includes a plurality of RF amplifiers and a functionally equal number of signal sensors, each of said plurality of RF amplifiers being for driving a different pole of the multipolar ablation device, each of said equal number of signal sensors being for sensing the operating parameters of said different pole of the multipolar ablation device.
PCT/US1996/019746 1995-12-08 1996-11-27 Radio frequency energy delivery system for multipolar electrode catheters WO1997020510A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96943705A EP0866675B1 (en) 1995-12-08 1996-11-27 Radio frequency energy delivery system for multipolar electrode catheters
DE69630393T DE69630393T2 (en) 1995-12-08 1996-11-27 RF ENERGY DELIVERY SYSTEM FOR MULTIPOLAR ELECTRODE CATHETERS
JP52149797A JP3746521B2 (en) 1995-12-08 1996-11-27 High frequency energy delivery system for multipolar electrode catheters

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US569,771 1995-12-08
US08/569,771 US5837001A (en) 1995-12-08 1995-12-08 Radio frequency energy delivery system for multipolar electrode catheters

Publications (1)

Publication Number Publication Date
WO1997020510A1 true WO1997020510A1 (en) 1997-06-12

Family

ID=24276786

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/019746 WO1997020510A1 (en) 1995-12-08 1996-11-27 Radio frequency energy delivery system for multipolar electrode catheters

Country Status (6)

Country Link
US (2) US5837001A (en)
EP (3) EP0866675B1 (en)
JP (1) JP3746521B2 (en)
DE (2) DE69635722T2 (en)
ES (2) ES2210403T3 (en)
WO (1) WO1997020510A1 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017672A1 (en) * 1997-10-06 1999-04-15 Somnus Medical Technologies, Inc. Electro-surgical instrument with a graphical user interface
WO1999022659A1 (en) * 1997-10-31 1999-05-14 C.R. Bard, Inc. Ring electrode structure for diagnostic and ablation catheters
DE19757720A1 (en) * 1997-12-23 1999-06-24 Sulzer Osypka Gmbh Method for operating a high-frequency ablation device and device for high-frequency tissue ablation
US5954717A (en) * 1997-09-25 1999-09-21 Radiotherapeutics Corporation Method and system for heating solid tissue
WO1999052461A1 (en) 1998-04-15 1999-10-21 BIOTRONIK MESS- UND THERAPIEGERäTE GMBH & CO. INGENIEURBüRO BERLIN Ablation system
US6035238A (en) * 1997-08-13 2000-03-07 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6081749A (en) * 1997-08-13 2000-06-27 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6139569A (en) * 1998-07-31 2000-10-31 Surx, Inc. Interspersed heating/cooling to shrink tissues for incontinence
US6156060A (en) * 1998-07-31 2000-12-05 Surx, Inc. Static devices and methods to shrink tissues for incontinence
US6236891B1 (en) 1998-07-31 2001-05-22 Surx, Inc. Limited heat transfer devices and methods to shrink tissues
US6322584B2 (en) 1998-07-31 2001-11-27 Surx, Inc. Temperature sensing devices and methods to shrink tissues
US6572639B1 (en) 1998-07-31 2003-06-03 Surx, Inc. Interspersed heating/cooling to shrink tissues for incontinence
US6685700B2 (en) 1997-09-25 2004-02-03 Radiotherapeutics Corporation Method and system for heating solid tissue
US6751507B2 (en) 1999-09-10 2004-06-15 Solarant Medical, Inc. Endopelvic fascia treatment for incontinence
US7004942B2 (en) 1998-01-14 2006-02-28 Solarant Medical, Inc. Ribbed electrodes and methods for their use
WO2006068243A1 (en) * 2004-12-24 2006-06-29 Olympus Medical Systems Corp. Heat generating treatment apparatus
US7317949B2 (en) 1996-11-08 2008-01-08 Ams Research Corporation Energy induced bulking and buttressing of tissues for incontinence
US8364237B2 (en) 2005-03-28 2013-01-29 Vessix Vascular, Inc. Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US8401667B2 (en) 2008-11-17 2013-03-19 Vessix Vascular, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
US8920414B2 (en) 2004-09-10 2014-12-30 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US8968284B2 (en) 2000-10-02 2015-03-03 Verathon Inc. Apparatus and methods for treating female urinary incontinence
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US9125667B2 (en) 2004-09-10 2015-09-08 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US9125666B2 (en) 2003-09-12 2015-09-08 Vessix Vascular, Inc. Selectable eccentric remodeling and/or ablation of atherosclerotic material
US9277955B2 (en) 2010-04-09 2016-03-08 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
US9974607B2 (en) 2006-10-18 2018-05-22 Vessix Vascular, Inc. Inducing desirable temperature effects on body tissue

Families Citing this family (293)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733495B1 (en) 1999-09-08 2004-05-11 Curon Medical, Inc. Systems and methods for monitoring and controlling use of medical devices
DE29519651U1 (en) * 1995-12-14 1996-02-01 Muntermann, Axel, 35583 Wetzlar Device for linear radio frequency catheter ablation of endomyocardial tissue
US7141049B2 (en) * 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US6458121B1 (en) * 1996-03-19 2002-10-01 Diapulse Corporation Of America Apparatus for athermapeutic medical treatments
DE19721362B4 (en) * 1997-04-01 2011-05-26 Axel Muntermann Device and calibration method for catheter ablation
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US6358245B1 (en) * 1998-02-19 2002-03-19 Curon Medical, Inc. Graphical user interface for association with an electrode structure deployed in contact with a tissue region
US8906010B2 (en) 1998-02-19 2014-12-09 Mederi Therapeutics, Inc. Graphical user interface for association with an electrode structure deployed in contact with a tissue region
US6558378B2 (en) 1998-05-05 2003-05-06 Cardiac Pacemakers, Inc. RF ablation system and method having automatic temperature control
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7137980B2 (en) 1998-10-23 2006-11-21 Sherwood Services Ag Method and system for controlling output of RF medical generator
US6190382B1 (en) 1998-12-14 2001-02-20 Medwaves, Inc. Radio-frequency based catheter system for ablation of body tissues
US20070066972A1 (en) * 2001-11-29 2007-03-22 Medwaves, Inc. Ablation catheter apparatus with one or more electrodes
US7004938B2 (en) * 2001-11-29 2006-02-28 Medwaves, Inc. Radio-frequency-based catheter system with improved deflection and steering mechanisms
US6208888B1 (en) 1999-02-03 2001-03-27 Cardiac Pacemakers, Inc. Voltage sensing system with input impedance balancing for electrocardiogram (ECG) sensing applications
US6162217A (en) * 1999-04-21 2000-12-19 Oratec Interventions, Inc. Method and apparatus for controlling a temperature-controlled probe
US6332881B1 (en) 1999-09-01 2001-12-25 Cardima, Inc. Surgical ablation tool
WO2001017452A1 (en) 1999-09-08 2001-03-15 Curon Medical, Inc. System for controlling a family of treatment devices
JP2003523225A (en) 1999-09-08 2003-08-05 キューロン メディカル,インコーポレイテッド Systems and methods for monitoring and controlling use of medical devices
US6385476B1 (en) 1999-09-21 2002-05-07 Biosense, Inc. Method and apparatus for intracardially surveying a condition of a chamber of a heart
US6368285B1 (en) 1999-09-21 2002-04-09 Biosense, Inc. Method and apparatus for mapping a chamber of a heart
US6546271B1 (en) 1999-10-01 2003-04-08 Bioscience, Inc. Vascular reconstruction
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US6496721B1 (en) 2000-04-28 2002-12-17 Cardiac Pacemakers, Inc. Automatic input impedance balancing for electrocardiogram (ECG) sensing applications
US8845632B2 (en) 2000-05-18 2014-09-30 Mederi Therapeutics, Inc. Graphical user interface for monitoring and controlling use of medical devices
US6511478B1 (en) * 2000-06-30 2003-01-28 Scimed Life Systems, Inc. Medical probe with reduced number of temperature sensor wires
US6425894B1 (en) * 2000-07-12 2002-07-30 Biosense Webster, Inc. Ablation catheter with electrode temperature monitoring
US6650927B1 (en) 2000-08-18 2003-11-18 Biosense, Inc. Rendering of diagnostic imaging data on a three-dimensional map
US6725085B2 (en) 2000-09-22 2004-04-20 Armin Schwartzman Method and apparatus for characterizing cardiac tissue from local electrograms
US6633773B1 (en) 2000-09-29 2003-10-14 Biosene, Inc. Area of interest reconstruction for surface of an organ using location data
EP1326549B1 (en) * 2000-10-17 2005-12-21 Asthmatx, Inc. Modification of airways by application of energy
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US6752804B2 (en) 2000-12-28 2004-06-22 Cardiac Pacemakers, Inc. Ablation system and method having multiple-sensor electrodes to assist in assessment of electrode and sensor position and adjustment of energy levels
US6540733B2 (en) * 2000-12-29 2003-04-01 Corazon Technologies, Inc. Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion
US6989010B2 (en) * 2001-04-26 2006-01-24 Medtronic, Inc. Ablation system and method of use
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US7250048B2 (en) * 2001-04-26 2007-07-31 Medtronic, Inc. Ablation system and method of use
US6635056B2 (en) 2001-10-09 2003-10-21 Cardiac Pacemakers, Inc. RF ablation apparatus and method using amplitude control
US6796980B2 (en) * 2001-11-21 2004-09-28 Cardiac Pacemakers, Inc. System and method for validating and troubleshooting ablation system set-up
US7674258B2 (en) * 2002-09-24 2010-03-09 Endoscopic Technologies, Inc. (ESTECH, Inc.) Electrophysiology electrode having multiple power connections and electrophysiology devices including the same
US6932816B2 (en) * 2002-02-19 2005-08-23 Boston Scientific Scimed, Inc. Apparatus for converting a clamp into an electrophysiology device
US6963772B2 (en) * 2002-04-17 2005-11-08 The Board Of Trustees Of The Leland Stanford Junior University User-retainable temperature and impedance monitoring methods and devices
US7008417B2 (en) 2002-04-22 2006-03-07 Medtronics, Inc. Detecting coagulum formation
US6730078B2 (en) 2002-04-22 2004-05-04 Cardiac Pacemakers, Inc. RF ablation apparatus and method using multi-frequency energy delivery
CN1329008C (en) 2002-06-19 2007-08-01 帕洛玛医疗技术公司 Method and apparatus for treatment of cutaneous and subcutaneous conditions
US20040082947A1 (en) 2002-10-25 2004-04-29 The Regents Of The University Of Michigan Ablation catheters
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
US7357800B2 (en) * 2003-02-14 2008-04-15 Boston Scientific Scimed, Inc. Power supply and control apparatus and electrophysiology systems including the same
US20070276361A1 (en) * 2003-03-28 2007-11-29 Debbie Stevens-Wright Method and apparatus for adjusting electrode dimensions
JP2006525096A (en) 2003-05-01 2006-11-09 シャーウッド・サービシーズ・アクチェンゲゼルシャフト Method and system for programming and controlling an electrosurgical generator system
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
US6973339B2 (en) 2003-07-29 2005-12-06 Biosense, Inc Lasso for pulmonary vein mapping and ablation
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
JP4977600B2 (en) 2004-04-20 2012-07-18 ジェンザイム・コーポレーション Surgical mesh implant
WO2006015354A2 (en) * 2004-07-30 2006-02-09 Washington University In St. Louis Electrosurgical systems and methods
US7549988B2 (en) 2004-08-30 2009-06-23 Boston Scientific Scimed, Inc. Hybrid lesion formation apparatus, systems and methods
US20070016272A1 (en) * 2004-09-27 2007-01-18 Thompson Russell B Systems and methods for treating a hollow anatomical structure
US7628786B2 (en) 2004-10-13 2009-12-08 Covidien Ag Universal foot switch contact port
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
WO2006052940A2 (en) 2004-11-05 2006-05-18 Asthmatx, Inc. Medical device with procedure improvement features
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US20070093802A1 (en) * 2005-10-21 2007-04-26 Danek Christopher J Energy delivery devices and methods
US8617152B2 (en) 2004-11-15 2013-12-31 Medtronic Ablation Frontiers Llc Ablation system with feedback
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
JP4958896B2 (en) * 2005-04-21 2012-06-20 アスマティックス,インコーポレイテッド Control method and apparatus for energy delivery
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US7578816B2 (en) * 2005-04-22 2009-08-25 Abl Technologies, Llc Method and system of increasing safety of cardiac ablation procedures
US7588567B2 (en) 2005-04-22 2009-09-15 Abl Technologies, Llc Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures
US20060247615A1 (en) * 2005-04-28 2006-11-02 Boston Scientific Scimed, Inc. Multi-element bi-polar ablation electrode
US8728072B2 (en) * 2005-05-12 2014-05-20 Aesculap Ag Electrocautery method and apparatus
US7942874B2 (en) 2005-05-12 2011-05-17 Aragon Surgical, Inc. Apparatus for tissue cauterization
US8696662B2 (en) 2005-05-12 2014-04-15 Aesculap Ag Electrocautery method and apparatus
US9339323B2 (en) * 2005-05-12 2016-05-17 Aesculap Ag Electrocautery method and apparatus
EP2759276A1 (en) 2005-06-20 2014-07-30 Medtronic Ablation Frontiers LLC Ablation catheter
US7655003B2 (en) 2005-06-22 2010-02-02 Smith & Nephew, Inc. Electrosurgical power control
AU2006268238A1 (en) 2005-07-11 2007-01-18 Medtronic Ablation Frontiers Llc Low power tissue ablation system
US20070100405A1 (en) 2005-07-21 2007-05-03 Thompson Russell B Systems and methods for treating a hollow anatomical structure
ATE480198T1 (en) * 2005-08-02 2010-09-15 Neurotherm Inc APPARATUS TO DIAGNOSE AND TREAT NERVOUS DYSFUNCTION
EP1754512A3 (en) * 2005-08-18 2008-03-05 Neurotherm, Inc. Method and apparatus for diagnosing and treating neural dysfunction
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
US8603084B2 (en) 2005-12-06 2013-12-10 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the formation of a lesion in tissue
US9492226B2 (en) 2005-12-06 2016-11-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Graphical user interface for real-time RF lesion depth display
JP5426171B2 (en) 2005-12-06 2014-02-26 セント・ジュード・メディカル・エイトリアル・フィブリレーション・ディヴィジョン・インコーポレーテッド Evaluation of electrode coupling for tissue ablation
US8406866B2 (en) 2005-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US8449535B2 (en) * 2005-12-06 2013-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US10362959B2 (en) * 2005-12-06 2019-07-30 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the proximity of an electrode to tissue in a body
US20090177111A1 (en) * 2006-12-06 2009-07-09 Miller Stephan P System and method for displaying contact between a catheter and tissue
US8998890B2 (en) 2005-12-06 2015-04-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Assessment of electrode coupling for tissue ablation
US8403925B2 (en) 2006-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing lesions in tissue
US9254163B2 (en) 2005-12-06 2016-02-09 St. Jude Medical, Atrial Fibrillation Division, Inc. Assessment of electrode coupling for tissue ablation
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
CA2574934C (en) 2006-01-24 2015-12-29 Sherwood Services Ag System and method for closed loop monitoring of monopolar electrosurgical apparatus
MX2008010892A (en) * 2006-02-22 2009-01-23 Custom Med Applications Inc Ablation instruments and related methods.
US7942872B2 (en) * 2006-02-27 2011-05-17 Moshe Ein-Gal Blended monopolar and bipolar application of RF energy
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
US7651492B2 (en) 2006-04-24 2010-01-26 Covidien Ag Arc based adaptive control system for an electrosurgical unit
US8574229B2 (en) 2006-05-02 2013-11-05 Aesculap Ag Surgical tool
JP2009540954A (en) * 2006-06-20 2009-11-26 エーオーテックス, インコーポレイテッド Prosthetic valve implantation site preparation technology
EP2465470B1 (en) 2006-06-28 2015-10-28 Medtronic Ardian Luxembourg S.à.r.l. Systems for thermally-induced renal neuromodulation
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US7794457B2 (en) 2006-09-28 2010-09-14 Covidien Ag Transformer for RF voltage sensing
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
US8641704B2 (en) 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
KR20100039332A (en) * 2007-06-08 2010-04-15 싸이노슈어, 인코포레이티드 Thermal surgery safety suite
US20080312651A1 (en) * 2007-06-15 2008-12-18 Karl Pope Apparatus and methods for selective heating of tissue
US8777945B2 (en) 2007-06-29 2014-07-15 Covidien Lp Method and system for monitoring tissue during an electrosurgical procedure
US8235983B2 (en) 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US9108052B2 (en) * 2007-07-24 2015-08-18 Asthmatx, Inc. System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices
US8152800B2 (en) 2007-07-30 2012-04-10 Vivant Medical, Inc. Electrosurgical systems and printed circuit boards for use therewith
US20090082762A1 (en) * 2007-09-20 2009-03-26 Ormsby Theodore C Radio frequency energy transmission device for the ablation of biological tissues
US9204927B2 (en) 2009-05-13 2015-12-08 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for presenting information representative of lesion formation in tissue during an ablation procedure
US10660690B2 (en) * 2007-12-28 2020-05-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for measurement of an impedance using a catheter such as an ablation catheter
US8290578B2 (en) 2007-12-28 2012-10-16 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for complex impedance compensation
US8870867B2 (en) 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
US8343144B2 (en) * 2008-02-11 2013-01-01 Expandoheat, Llc Apparatus and method for vessel sealing and tissue coagulation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US9575140B2 (en) 2008-04-03 2017-02-21 Covidien Lp Magnetic interference detection system and method
US8301264B2 (en) * 2008-04-25 2012-10-30 Urologix, Inc. Thermal therapy temperature sensor calibration method
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8133222B2 (en) * 2008-05-28 2012-03-13 Medwaves, Inc. Tissue ablation apparatus and method using ultrasonic imaging
WO2009147671A1 (en) 2008-06-03 2009-12-10 Superdimension Ltd. Feature-based registration method
US8172835B2 (en) * 2008-06-05 2012-05-08 Cutera, Inc. Subcutaneous electric field distribution system and methods
US20090306647A1 (en) * 2008-06-05 2009-12-10 Greg Leyh Dynamically controllable multi-electrode apparatus & methods
US8218847B2 (en) 2008-06-06 2012-07-10 Superdimension, Ltd. Hybrid registration method
US8206385B2 (en) * 2008-06-09 2012-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter assembly with front-loaded tip and multi-contact connector
US8679106B2 (en) * 2008-07-01 2014-03-25 Medwaves, Inc. Angioplasty and tissue ablation apparatus and method
US20100022999A1 (en) * 2008-07-24 2010-01-28 Gollnick David A Symmetrical rf electrosurgical system and methods
US9700366B2 (en) * 2008-08-01 2017-07-11 Covidien Lp Polyphase electrosurgical system and method
US8172836B2 (en) 2008-08-11 2012-05-08 Tyco Healthcare Group Lp Electrosurgical system having a sensor for monitoring smoke or aerosols
US8377053B2 (en) 2008-09-05 2013-02-19 Covidien Lp Electrosurgical apparatus with high speed energy recovery
US8242782B2 (en) 2008-09-30 2012-08-14 Vivant Medical, Inc. Microwave ablation generator control system
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
CN102202591A (en) * 2008-10-28 2011-09-28 史密夫和内修有限公司 Electrosurgical device with controllable electric field profile
US8262652B2 (en) 2009-01-12 2012-09-11 Tyco Healthcare Group Lp Imaginary impedance process monitoring and intelligent shut-off
US20100211060A1 (en) * 2009-02-13 2010-08-19 Cutera, Inc. Radio frequency treatment of subcutaneous fat
US8211097B2 (en) * 2009-02-13 2012-07-03 Cutera, Inc. Optimizing RF power spatial distribution using frequency control
GB0906572D0 (en) 2009-04-16 2009-05-20 Gyrus Medical Ltd A surgical instrument
US20100280508A1 (en) * 2009-05-01 2010-11-04 Joseph Charles Eder Method and Apparatus for RF Anastomosis
CN102711642B (en) 2009-09-22 2015-04-29 麦迪尼治疗公司 Systems and methods for controlling use and operation of a family of different treatment devices
US10386990B2 (en) 2009-09-22 2019-08-20 Mederi Rf, Llc Systems and methods for treating tissue with radiofrequency energy
US9474565B2 (en) 2009-09-22 2016-10-25 Mederi Therapeutics, Inc. Systems and methods for treating tissue with radiofrequency energy
US9750563B2 (en) 2009-09-22 2017-09-05 Mederi Therapeutics, Inc. Systems and methods for treating tissue with radiofrequency energy
US9775664B2 (en) 2009-09-22 2017-10-03 Mederi Therapeutics, Inc. Systems and methods for treating tissue with radiofrequency energy
CN104042322B (en) 2009-10-27 2017-06-06 赫莱拉公司 Delivery apparatus with coolable energy transmitting device
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US10039588B2 (en) 2009-12-16 2018-08-07 Covidien Lp System and method for tissue sealing
CA2766945A1 (en) 2010-02-04 2011-08-11 Aesculap Ag Laparoscopic radiofrequency surgical device
US8454590B2 (en) 2010-02-26 2013-06-04 Covidien Lp Enhanced lossless current sense circuit
US8419727B2 (en) 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8668690B2 (en) 2010-06-03 2014-03-11 Covidien Lp Apparatus and method for optimal tissue separation
US8617154B2 (en) 2010-06-25 2013-12-31 Covidien Lp Current-fed push-pull converter with passive voltage clamp
US8623007B2 (en) 2010-06-30 2014-01-07 Covidien Lp Electrosurgical generator to ablation device adaptor
US8636730B2 (en) 2010-07-12 2014-01-28 Covidien Lp Polarity control of electrosurgical generator
US8641712B2 (en) 2010-07-28 2014-02-04 Covidien Lp Local optimization of electrode current densities
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
WO2012061153A1 (en) 2010-10-25 2012-05-10 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems and methods for evaluation and feedback of neuromodulation treatment
US9005193B2 (en) 2010-11-08 2015-04-14 Biosense Webster (Israel) Ltd. Multichannel ablation with frequency differentiation
US9005192B2 (en) 2010-11-08 2015-04-14 Biosense Webster (Israel) Ltd. Simultaneous ablation by multiple electrodes
US9028481B2 (en) 2011-01-05 2015-05-12 Covidien Lp System and method for measuring current of an electrosurgical generator
US9265560B2 (en) 2011-02-25 2016-02-23 Covidien Lp System and method for detecting and suppressing arc formation during an electrosurgical procedure
US9375247B2 (en) 2011-03-16 2016-06-28 Covidien Lp System and method for electrosurgical generator power measurement
US9539050B2 (en) 2011-04-12 2017-01-10 Covidien Lp System and method for process monitoring and intelligent shut-off
US8968293B2 (en) * 2011-04-12 2015-03-03 Covidien Lp Systems and methods for calibrating power measurements in an electrosurgical generator
US9050089B2 (en) 2011-05-31 2015-06-09 Covidien Lp Electrosurgical apparatus with tissue site sensing and feedback control
US9339327B2 (en) 2011-06-28 2016-05-17 Aesculap Ag Electrosurgical tissue dissecting device
US9028479B2 (en) 2011-08-01 2015-05-12 Covidien Lp Electrosurgical apparatus with real-time RF tissue energy control
DE102011110667B4 (en) 2011-08-19 2018-11-15 Omar Omar-Pasha Apparatus for applying a pulsed radiofrequency therapy in the vascular system or other body cavities or tissue of the human or animal body, as well as a catheter, a probe and an insertion aid for such a device
US9033973B2 (en) 2011-08-30 2015-05-19 Covidien Lp System and method for DC tissue impedance sensing
US9099863B2 (en) 2011-09-09 2015-08-04 Covidien Lp Surgical generator and related method for mitigating overcurrent conditions
US9033970B2 (en) 2011-09-20 2015-05-19 Covidien Lp Handheld medical devices including microwave amplifier unit at device handle
US9039693B2 (en) 2011-09-20 2015-05-26 Covidien Lp Handheld medical devices including microwave amplifier unit at device handle
US8745846B2 (en) 2011-09-20 2014-06-10 Covidien Lp Method of manufacturing handheld medical devices including microwave amplifier unit
US9023025B2 (en) 2011-09-20 2015-05-05 Covidien Lp Handheld medical devices including microwave amplifier unit at device handle
US9039692B2 (en) 2011-09-20 2015-05-26 Covidien Lp Handheld medical devices including microwave amplifier unit at device handle
US10376301B2 (en) 2011-09-28 2019-08-13 Covidien Lp Logarithmic amplifier, electrosurgical generator including same, and method of controlling electrosurgical generator using same
DE102011085501A1 (en) * 2011-10-31 2013-05-02 Söring GmbH ESU
US10076383B2 (en) 2012-01-25 2018-09-18 Covidien Lp Electrosurgical device having a multiplexer
US9480523B2 (en) 2012-01-27 2016-11-01 Covidien Lp Systems and methods for phase predictive impedance loss model calibration and compensation
US9037447B2 (en) 2012-01-27 2015-05-19 Covidien Lp Systems and methods for phase predictive impedance loss model calibration and compensation
US8664934B2 (en) 2012-01-27 2014-03-04 Covidien Lp System and method for verifying the operating frequency of digital control circuitry
US8968290B2 (en) 2012-03-14 2015-03-03 Covidien Lp Microwave ablation generator control system
US8653994B2 (en) 2012-03-21 2014-02-18 Covidien Lp System and method for detection of ADC errors
US9198711B2 (en) 2012-03-22 2015-12-01 Covidien Lp Electrosurgical system for communicating information embedded in an audio tone
US9375250B2 (en) 2012-04-09 2016-06-28 Covidien Lp Method for employing single fault safe redundant signals
US8932291B2 (en) 2012-04-13 2015-01-13 Covidien Lp Electrosurgical systems
EP2839552A4 (en) 2012-04-18 2015-12-30 Cynosure Inc Picosecond laser apparatus and methods for treating target tissues with same
US9375249B2 (en) 2012-05-11 2016-06-28 Covidien Lp System and method for directing energy to tissue
US9192424B2 (en) 2012-05-31 2015-11-24 Covidien Lp AC active load
US9770293B2 (en) 2012-06-04 2017-09-26 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
US9192425B2 (en) 2012-06-26 2015-11-24 Covidien Lp System and method for testing electrosurgical generators
US9529025B2 (en) 2012-06-29 2016-12-27 Covidien Lp Systems and methods for measuring the frequency of signals generated by high frequency medical devices
WO2014018153A1 (en) 2012-07-24 2014-01-30 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US20140067029A1 (en) * 2012-08-28 2014-03-06 Boston Scientific Scimed, Inc. Renal nerve modulation and ablation catheter electrode design
EP2997922B1 (en) 2012-09-26 2017-12-20 Aesculap AG Apparatus for tissue cutting and sealing
US9861425B2 (en) 2012-10-02 2018-01-09 Covidien Lp System and method for using resonance phasing for measuring impedance
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
WO2014071372A1 (en) 2012-11-05 2014-05-08 Boston Scientific Scimed, Inc. Devices for delivering energy to body lumens
SG11201504119VA (en) * 2012-12-09 2015-06-29 Autonomix Medical Inc Regulating organ and tumor growth rates, function, and development
US9204921B2 (en) 2012-12-13 2015-12-08 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9364277B2 (en) 2012-12-13 2016-06-14 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9921243B2 (en) 2012-12-17 2018-03-20 Covidien Lp System and method for voltage and current sensing
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9456862B2 (en) 2013-02-19 2016-10-04 Covidien Lp Electrosurgical generator and system
US9895186B2 (en) 2013-03-11 2018-02-20 Covidien Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator
US9519021B2 (en) 2013-03-11 2016-12-13 Covidien Lp Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator
US10842563B2 (en) 2013-03-15 2020-11-24 Covidien Lp System and method for power control of electrosurgical resonant inverters
EP3751684A1 (en) 2013-03-15 2020-12-16 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US9498276B2 (en) 2013-03-15 2016-11-22 Covidien Lp Systems and methods for narrowband real impedance control in electrosurgery
US9283028B2 (en) 2013-03-15 2016-03-15 Covidien Lp Crest-factor control of phase-shifted inverter
US9504516B2 (en) 2013-05-31 2016-11-29 Covidien LLP Gain compensation for a full bridge inverter
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US9559594B2 (en) 2013-06-24 2017-01-31 Covidien Lp Dead-time optimization of resonant inverters
US10729484B2 (en) 2013-07-16 2020-08-04 Covidien Lp Electrosurgical generator with continuously and arbitrarily variable crest factor
US10610285B2 (en) 2013-07-19 2020-04-07 Covidien Lp Electrosurgical generators
US9872719B2 (en) 2013-07-24 2018-01-23 Covidien Lp Systems and methods for generating electrosurgical energy using a multistage power converter
US10285750B2 (en) 2013-07-29 2019-05-14 Covidien Lp Systems and methods for operating an electrosurgical generator
US9655670B2 (en) 2013-07-29 2017-05-23 Covidien Lp Systems and methods for measuring tissue impedance through an electrosurgical cable
CN105451680B (en) 2013-08-09 2019-10-08 波士顿科学国际有限公司 The correlation technique of expansible conduit and manufacture and use
US9770283B2 (en) 2013-09-24 2017-09-26 Covidien Lp Systems and methods for improving efficiency of electrosurgical generators
US9839469B2 (en) 2013-09-24 2017-12-12 Covidien Lp Systems and methods for improving efficiency of electrosurgical generators
US9867651B2 (en) 2013-09-26 2018-01-16 Covidien Lp Systems and methods for estimating tissue parameters using surgical devices
US10058374B2 (en) 2013-09-26 2018-08-28 Covidien Lp Systems and methods for estimating tissue parameters using surgical devices
US10130412B2 (en) 2013-09-26 2018-11-20 Covidien Lp Systems and methods for estimating tissue parameters using surgical devices
US9913679B2 (en) 2013-10-16 2018-03-13 Covidien Lp Electrosurgical systems and methods for monitoring power dosage
US10105172B2 (en) 2013-10-16 2018-10-23 Covidien Lp Radiofrequency amplifier impedance optimization
US10188446B2 (en) 2013-10-16 2019-01-29 Covidien Lp Resonant inverter
US10433902B2 (en) 2013-10-23 2019-10-08 Medtronic Ardian Luxembourg S.A.R.L. Current control methods and systems
US9642670B2 (en) 2013-10-29 2017-05-09 Covidien Lp Resonant inverter with a common mode choke
US9901386B2 (en) 2014-01-13 2018-02-27 Covidien Lp Systems and methods for multifrequency cable compensation
US20150272655A1 (en) * 2014-03-27 2015-10-01 Medtronic Ablation Frontiers, Llc Controlled rf energy in a multi-electrode catheter
US10492850B2 (en) 2014-04-04 2019-12-03 Covidien Lp Systems and methods for calculating tissue impedance in electrosurgery
US9987068B2 (en) 2014-04-04 2018-06-05 Covidien Lp Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators
US9974595B2 (en) 2014-04-04 2018-05-22 Covidien Lp Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators
US9949783B2 (en) 2014-04-04 2018-04-24 Covidien Lp Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators
US10610292B2 (en) 2014-04-25 2020-04-07 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology
KR20170107428A (en) 2014-11-19 2017-09-25 어드밴스드 카디악 테라퓨틱스, 인크. Ablation devices, systems and methods of using a high-resolution electrode assembly
WO2016081611A1 (en) 2014-11-19 2016-05-26 Advanced Cardiac Therapeutics, Inc. High-resolution mapping of tissue with pacing
WO2016081606A1 (en) 2014-11-19 2016-05-26 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
US10188448B2 (en) 2014-11-21 2019-01-29 Covidien Lp Electrosurgical system for multi-frequency interrogation of parasitic parameters of an electrosurgical instrument
US10278764B2 (en) 2014-12-02 2019-05-07 Covidien Lp Electrosurgical generators and sensors
US10292753B2 (en) 2014-12-02 2019-05-21 Covidien Lp Electrosurgical generators and sensors
US9782212B2 (en) 2014-12-02 2017-10-10 Covidien Lp High level algorithms
US10281496B2 (en) 2014-12-02 2019-05-07 Covidien Lp Electrosurgical generators and sensors
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US10363084B2 (en) 2015-04-01 2019-07-30 Covidien Lp Interdigitation of waveforms for dual-output electrosurgical generators
US11090106B2 (en) 2015-04-23 2021-08-17 Covidien Lp Control systems for electrosurgical generator
US10617463B2 (en) 2015-04-23 2020-04-14 Covidien Lp Systems and methods for controlling power in an electrosurgical generator
US10507056B2 (en) 2015-10-01 2019-12-17 General Electric Company System and method for representation and visualization of catheter applied force and power
SG11201807618QA (en) 2016-03-15 2018-10-30 Epix Therapeutics Inc Improved devices, systems and methods for irrigated ablation
US10933250B2 (en) 2016-04-22 2021-03-02 Syneron Medical Ltd. Skin treatment apparatus and method
US10772673B2 (en) * 2016-05-02 2020-09-15 Covidien Lp Surgical energy system with universal connection features
US10869712B2 (en) 2016-05-02 2020-12-22 Covidien Lp System and method for high frequency leakage reduction through selective harmonic elimination in electrosurgical generators
US10610287B2 (en) 2016-05-05 2020-04-07 Covidien Lp Advanced simultaneous activation algorithm
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US11197715B2 (en) 2016-08-02 2021-12-14 Covidien Lp Ablation cable assemblies and a method of manufacturing the same
US10376309B2 (en) 2016-08-02 2019-08-13 Covidien Lp Ablation cable assemblies and a method of manufacturing the same
US11065053B2 (en) 2016-08-02 2021-07-20 Covidien Lp Ablation cable assemblies and a method of manufacturing the same
US11006997B2 (en) 2016-08-09 2021-05-18 Covidien Lp Ultrasonic and radiofrequency energy production and control from a single power converter
US10418705B2 (en) 2016-10-28 2019-09-17 Covidien Lp Electromagnetic navigation antenna assembly and electromagnetic navigation system including the same
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
US10517505B2 (en) 2016-10-28 2019-12-31 Covidien Lp Systems, methods, and computer-readable media for optimizing an electromagnetic navigation system
US10615500B2 (en) 2016-10-28 2020-04-07 Covidien Lp System and method for designing electromagnetic navigation antenna assemblies
US10722311B2 (en) 2016-10-28 2020-07-28 Covidien Lp System and method for identifying a location and/or an orientation of an electromagnetic sensor based on a map
US10638952B2 (en) 2016-10-28 2020-05-05 Covidien Lp Methods, systems, and computer-readable media for calibrating an electromagnetic navigation system
US10751126B2 (en) 2016-10-28 2020-08-25 Covidien Lp System and method for generating a map for electromagnetic navigation
US10446931B2 (en) 2016-10-28 2019-10-15 Covidien Lp Electromagnetic navigation antenna assembly and electromagnetic navigation system including the same
US11717337B2 (en) * 2016-11-29 2023-08-08 St. Jude Medical, Cardiology Division, Inc. Electroporation systems and catheters for electroporation systems
EP3614946B1 (en) 2017-04-27 2024-03-20 EPiX Therapeutics, Inc. Determining nature of contact between catheter tip and tissue
AU2018257642B2 (en) 2017-04-28 2024-03-21 Stryker Corporation Control console and accessories for RF nerve ablation and methods of operating the same
US11666379B2 (en) 2017-07-06 2023-06-06 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation with multiple electrodes
US10945781B2 (en) 2017-09-07 2021-03-16 Biosense Webster (Israel) Ltd. Variable phase generation and detection for radio-frequency (RF) ablation
US11534226B2 (en) 2017-09-22 2022-12-27 Covidien Lp Systems and methods for minimizing arcing of bipolar forceps
US11744631B2 (en) 2017-09-22 2023-09-05 Covidien Lp Systems and methods for controlled electrosurgical coagulation
US11272975B2 (en) 2017-09-22 2022-03-15 Covidien Lp Systems and methods for controlled electrosurgical dissection
KR102028413B1 (en) * 2017-11-28 2019-10-04 주식회사 청우메디칼 A Surgical Apparatus Having a Structure of Multiple Resonant Electrodes
US12082917B2 (en) 2018-01-24 2024-09-10 Medtronic Ireland Manufacturing Unlimited Company Systems, devices, and methods for assessing efficacy of renal neuromodulation therapy
US11116563B2 (en) * 2018-02-15 2021-09-14 Biosense Webster (Israel) Ltd. Multi-channel RF ablation
KR102627248B1 (en) 2018-02-26 2024-01-19 싸이노슈어, 엘엘씨 Q-switched cavity dumping subnanosecond laser
US11224474B2 (en) * 2018-02-28 2022-01-18 Prostacare Pty Ltd System for managing high impedance changes in a non-thermal ablation system for BPH
US12089902B2 (en) 2019-07-30 2024-09-17 Coviden Lp Cone beam and 3D fluoroscope lung navigation
WO2021065876A1 (en) * 2019-09-30 2021-04-08 テルモ株式会社 Energy generating device and cauterization system
US11911087B2 (en) 2020-08-07 2024-02-27 Biosig Technologies, Inc. Controlled switching network for electrophysiology procedures
CN112244993B (en) * 2020-10-31 2022-03-15 杭州诺生医疗科技有限公司 Radio frequency ablation instrument
CN114504373A (en) * 2020-11-16 2022-05-17 澳美力科技(成都)有限公司 Novel radio frequency conversion beauty instrument

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304214A (en) * 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
WO1994010922A1 (en) * 1992-11-13 1994-05-26 Ep Technologies, Inc. Cardial ablation systems using temperature monitoring
WO1995009576A1 (en) * 1993-10-07 1995-04-13 Valleylab, Inc. Automatic control for electrosurgical generator
WO1995010321A1 (en) * 1993-10-15 1995-04-20 Ep Technologies, Inc. Creating curvilinear lesions in body tissue
WO1995025472A1 (en) * 1994-03-23 1995-09-28 Vidamed, Inc. Dual-channel rf power delivery system

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3614521A (en) * 1969-11-28 1971-10-19 Us Air Force Multichannel multiplexed quasi three-dimensional display system
US3830223A (en) * 1972-09-18 1974-08-20 Technicon Instr Methodology and apparatus for non-invasive biophysical diagnosis
US3978470A (en) * 1974-07-10 1976-08-31 Midwest Analog And Digital, Inc. Multi-channel data color display apparatus
US4016886A (en) * 1974-11-26 1977-04-12 The United States Of America As Represented By The United States Energy Research And Development Administration Method for localizing heating in tumor tissue
US4095602A (en) * 1976-09-27 1978-06-20 Leveen Harry H Multi-portal radiofrequency generator
US4365639A (en) * 1980-02-07 1982-12-28 Applied Cardiac Electrophysiology Catheter, cardiac pacemaker and method of pacing
US4510937A (en) * 1983-10-28 1985-04-16 International Medical Electronics, Ltd. Method and apparatus for operating dual diathermy applicator heads in close proximity to one another
US4940064A (en) * 1986-11-14 1990-07-10 Desai Jawahar M Catheter for mapping and ablation and method therefor
US4869248A (en) * 1987-04-17 1989-09-26 Narula Onkar S Method and apparatus for localized thermal ablation
US4817608A (en) * 1987-05-29 1989-04-04 Mieczyslaw Mirowski Cardioverting transvenous catheter/patch electrode system and method for its use
US5249585A (en) * 1988-07-28 1993-10-05 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US4966597A (en) * 1988-11-04 1990-10-30 Cosman Eric R Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection
US4945912A (en) * 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US5057105A (en) * 1989-08-28 1991-10-15 The University Of Kansas Med Center Hot tip catheter assembly
US5122137A (en) * 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
US5233515A (en) * 1990-06-08 1993-08-03 Cosman Eric R Real-time graphic display of heat lesioning parameters in a clinical lesion generator system
DK19391D0 (en) * 1991-02-05 1991-02-05 Oeresund Kryolit PROCEDURE FOR THE EXTRACTION OF ALUMINUM AND FLUORES FROM FLUORABLE WASTE MATERIALS
JP3091253B2 (en) * 1991-04-25 2000-09-25 オリンパス光学工業株式会社 Thermal treatment equipment
US5620481A (en) * 1991-07-05 1997-04-15 Desai; Jawahar M. Device for multi-phase radio-frequency ablation
US5383917A (en) * 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5366443A (en) * 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
US5239999A (en) * 1992-03-27 1993-08-31 Cardiac Pathways Corporation Helical endocardial catheter probe
US5540681A (en) * 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5573533A (en) * 1992-04-10 1996-11-12 Medtronic Cardiorhythm Method and system for radiofrequency ablation of cardiac tissue
US5443470A (en) * 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5341807A (en) * 1992-06-30 1994-08-30 American Cardiac Ablation Co., Inc. Ablation catheter positioning system
US5433198A (en) * 1993-03-11 1995-07-18 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5582609A (en) * 1993-10-14 1996-12-10 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5454370A (en) * 1993-12-03 1995-10-03 Avitall; Boaz Mapping and ablation electrode configuration
US5584830A (en) * 1994-03-30 1996-12-17 Medtronic Cardiorhythm Method and system for radiofrequency ablation of cardiac tissue
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
WO1996000040A1 (en) * 1994-06-27 1996-01-04 Ep Technologies, Inc. Tissue ablation systems using temperature curve control
US5540684A (en) * 1994-07-28 1996-07-30 Hassler, Jr.; William L. Method and apparatus for electrosurgically treating tissue

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304214A (en) * 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
WO1994010922A1 (en) * 1992-11-13 1994-05-26 Ep Technologies, Inc. Cardial ablation systems using temperature monitoring
WO1995009576A1 (en) * 1993-10-07 1995-04-13 Valleylab, Inc. Automatic control for electrosurgical generator
WO1995010321A1 (en) * 1993-10-15 1995-04-20 Ep Technologies, Inc. Creating curvilinear lesions in body tissue
WO1995025472A1 (en) * 1994-03-23 1995-09-28 Vidamed, Inc. Dual-channel rf power delivery system

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7317949B2 (en) 1996-11-08 2008-01-08 Ams Research Corporation Energy induced bulking and buttressing of tissues for incontinence
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US6081749A (en) * 1997-08-13 2000-06-27 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6035238A (en) * 1997-08-13 2000-03-07 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US5954717A (en) * 1997-09-25 1999-09-21 Radiotherapeutics Corporation Method and system for heating solid tissue
US6685700B2 (en) 1997-09-25 2004-02-03 Radiotherapeutics Corporation Method and system for heating solid tissue
US6293941B1 (en) 1997-10-06 2001-09-25 Somnus Medical Technologies, Inc. Method and apparatus for impedance measurement in a multi-channel electro-surgical generator
US6139546A (en) * 1997-10-06 2000-10-31 Somnus Medical Technologies, Inc. Linear power control with digital phase lock
WO1999017672A1 (en) * 1997-10-06 1999-04-15 Somnus Medical Technologies, Inc. Electro-surgical instrument with a graphical user interface
US6165173A (en) * 1997-10-06 2000-12-26 Somnus Medical Technologies, Inc. Memory for regulating device utilization and behavior
US6228079B1 (en) 1997-10-06 2001-05-08 Somnus Medical Technology, Inc. Method and apparatus for power measurement in radio frequency electro-surgical generators
US6231569B1 (en) 1997-10-06 2001-05-15 Somnus Medical Technologies, Inc. Dual processor architecture for electro generator
WO1999022659A1 (en) * 1997-10-31 1999-05-14 C.R. Bard, Inc. Ring electrode structure for diagnostic and ablation catheters
DE19757720A1 (en) * 1997-12-23 1999-06-24 Sulzer Osypka Gmbh Method for operating a high-frequency ablation device and device for high-frequency tissue ablation
US6193713B1 (en) 1997-12-23 2001-02-27 Sulzer Osypka Gmbh Method for the operation of a high frequency ablation apparatus and apparatus for the high frequency tissue ablation
US7004942B2 (en) 1998-01-14 2006-02-28 Solarant Medical, Inc. Ribbed electrodes and methods for their use
US6319249B1 (en) 1998-04-15 2001-11-20 Biotronik Mess-Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Ablation system
WO1999052461A1 (en) 1998-04-15 1999-10-21 BIOTRONIK MESS- UND THERAPIEGERäTE GMBH & CO. INGENIEURBüRO BERLIN Ablation system
US6350263B1 (en) 1998-04-15 2002-02-26 BIOTRONIK MESS- UND THERAPIEGERäTE GMBH & CO. INGENIEURBURO BERLIN Ablating arrangement
US7470271B2 (en) 1998-07-31 2008-12-30 Ams Research Corporation Static devices and methods to shrink tissues for incontinence
US6322584B2 (en) 1998-07-31 2001-11-27 Surx, Inc. Temperature sensing devices and methods to shrink tissues
US6776779B1 (en) 1998-07-31 2004-08-17 Solarant Medical, Inc. Static devices and methods to shrink tissues for incontinence
US6156060A (en) * 1998-07-31 2000-12-05 Surx, Inc. Static devices and methods to shrink tissues for incontinence
US6236891B1 (en) 1998-07-31 2001-05-22 Surx, Inc. Limited heat transfer devices and methods to shrink tissues
US6572639B1 (en) 1998-07-31 2003-06-03 Surx, Inc. Interspersed heating/cooling to shrink tissues for incontinence
US6139569A (en) * 1998-07-31 2000-10-31 Surx, Inc. Interspersed heating/cooling to shrink tissues for incontinence
US7001379B2 (en) 1999-06-25 2006-02-21 Boston Scientific Scimed, Inc. Method and system for heating solid tissue
US6751507B2 (en) 1999-09-10 2004-06-15 Solarant Medical, Inc. Endopelvic fascia treatment for incontinence
US8968284B2 (en) 2000-10-02 2015-03-03 Verathon Inc. Apparatus and methods for treating female urinary incontinence
US9510901B2 (en) 2003-09-12 2016-12-06 Vessix Vascular, Inc. Selectable eccentric remodeling and/or ablation
US9125666B2 (en) 2003-09-12 2015-09-08 Vessix Vascular, Inc. Selectable eccentric remodeling and/or ablation of atherosclerotic material
US10188457B2 (en) 2003-09-12 2019-01-29 Vessix Vascular, Inc. Selectable eccentric remodeling and/or ablation
US9125667B2 (en) 2004-09-10 2015-09-08 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US8939970B2 (en) 2004-09-10 2015-01-27 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US8920414B2 (en) 2004-09-10 2014-12-30 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
WO2006068243A1 (en) * 2004-12-24 2006-06-29 Olympus Medical Systems Corp. Heat generating treatment apparatus
JP2006180936A (en) * 2004-12-24 2006-07-13 Olympus Medical Systems Corp Heating treatment device
US8364237B2 (en) 2005-03-28 2013-01-29 Vessix Vascular, Inc. Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures
US9486355B2 (en) 2005-05-03 2016-11-08 Vessix Vascular, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US10213252B2 (en) 2006-10-18 2019-02-26 Vessix, Inc. Inducing desirable temperature effects on body tissue
US10413356B2 (en) 2006-10-18 2019-09-17 Boston Scientific Scimed, Inc. System for inducing desirable temperature effects on body tissue
US9974607B2 (en) 2006-10-18 2018-05-22 Vessix Vascular, Inc. Inducing desirable temperature effects on body tissue
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
US9327100B2 (en) 2008-11-14 2016-05-03 Vessix Vascular, Inc. Selective drug delivery in a lumen
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US8401667B2 (en) 2008-11-17 2013-03-19 Vessix Vascular, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
US9277955B2 (en) 2010-04-09 2016-03-08 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue

Also Published As

Publication number Publication date
JP2000501628A (en) 2000-02-15
ES2210403T3 (en) 2004-07-01
DE69635722D1 (en) 2006-04-06
US5931835A (en) 1999-08-03
EP0866675A1 (en) 1998-09-30
ES2254839T3 (en) 2006-06-16
EP1047636A1 (en) 2000-11-02
DE69635722T2 (en) 2006-08-31
EP0866675B1 (en) 2003-10-15
JP3746521B2 (en) 2006-02-15
DE69630393T2 (en) 2004-07-22
EP1047636A4 (en) 2003-07-23
EP1366724A1 (en) 2003-12-03
DE69630393D1 (en) 2003-11-20
EP1366724B1 (en) 2006-01-11
US5837001A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
EP1366724B1 (en) Radio frequency energy delivery system for multipolar electrode catheters
US5954719A (en) System for operating a RF ablation generator
EP0904800B1 (en) Device and method for multi-phase radio-frequency ablation
US6761716B2 (en) System and method for assessing electrode-tissue contact and lesion quality during RF ablation by measurement of conduction time
US6488678B2 (en) RF ablation apparatus and method using unipolar and bipolar techniques
US6178354B1 (en) Internal mechanism for displacing a slidable electrode
US6485487B1 (en) RF ablation apparatus having high output impedance drivers
US6241726B1 (en) Catheter system having a tip section with fixation means
US20030187430A1 (en) System and method for measuring power at tissue during RF ablation
CA2308278A1 (en) Ring electrode structure for diagnostic and ablation catheters
US20230190364A1 (en) Systems and methods for monitoring return patch impedances
US6443950B1 (en) Ablation lead for atrial flutter
EP3733101A1 (en) Temperature controlled short duration ablation with resistive heating
Oeff et al. Ablation of ventricular tachycardia using multiple sequential transcatheter application of radiofrequency energy
US20240197198A1 (en) Decreasing iegm hazards in time division multiplexed system
Rouane et al. Intracardiac high-frequency catheter ablatherapy: technical aspects
GAISER CATHETER DESIGNS FOR INTERVENTIONAL

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996943705

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 521497

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996943705

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1996943705

Country of ref document: EP